FKnol.com

Financial Knowledge & Information Portal

Biotech Stocks Performance of 2019

Updated Sep 9, 2019
Biotechnology has emerged as one of the key areas of interest amid the Health Care sector. Hundreds of biotech companies have mushroomed whose size varies from 5 person teams to thousands of employees who are involved in path-breaking research, associated development, and attempts to find cure to a variety of diseases and ailments. Companies in the biotechnology subsector usually have a very high operating cost owing to their research-, development-, and testing-focused activities which may not only take years to complete, but the end result is also highly uncertain. Success may lead to the biotech company coming out with a high-price patented drug that can make millions or billions making the stock a multi-bagger, while a failure can lead to a complete wipeout of equity value. Investors in such biotech stocks should be prepared for a volatile change in stock prices.

As of writing, FKnol has the following Biotech stocks in its database. This article presents the performance of the Biotech stocks in a tabular form making it easy for individuals to sort the list on the desired parameters of preference. Details are based on the market data for the year 2019 till date. This article presents a list of all Biotech stocks, which can be sorted and assessed for the past performance of the Biotech stocks based on market capitalization values, stock price, price changes, percentage price changes and 52-week high-low price ranges. Percentage change is calculated based on the price changes observed from the end of the previous year to the date of Sep 9, 2019. See the List of Top 10 Biotech Stocks of 2019. Alternatively, one can also explore the List of Top Biotech ETFs.

This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.
Top 10 Biotech Stocks All Biotech Stocks All Biotech ETFs Top Dividend-paying Biotech Stocks

Performance of Biotech Stocks

No.Company (Ticker)
Market Cap
%YTD Gains
Company DescriptionStock Price
52-wk Low52-wk High
Sorted by Market Cap. Click on the arrow buttons to sort the table as per the desired column
1.Stellar Biotechnologies (SBOT)$264.85 billion32757921.98%Stellar Biotechnologies, Inc., a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North Ameri...See Company Profile ...Dividend History.$298098$0.75$6.18
2.Novo Nordisk (NVO)$119.29 billion9.96%Novo Nordisk A S, a healthcare company, engages in the development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Obesity, and Bi...See Company Profile ...Dividend History.$50.66$41.23$53.55
3.Vertex Pharma (VRTX)$44.61 billion5.5%Vertex Pharmaceuticals Incorporated, incorporated on January 4, 1989, is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for ...See Company Profile ...Dividend History.$174.81$151.8$195.81
4.Regeneron Pharma (REGN)$30.44 billion-25.3%Regeneron Pharmaceuticals, Inc., incorporated on January 11, 1988, is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes ...See Company Profile ...Dividend History.$279$278.72$442
5.Alexion Pharma (ALXN)$23.15 billion9.29%Alexion Pharmaceuticals, Inc., incorporated on January 28, 1992, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Companys products include Soliris (eculizumab), ...See Company Profile ...Dividend History.$106.4$92.56$141.86
6.Incyte (INCY)$17.54 billion24.19%Incyte Corporation, incorporated on April 8, 1991, is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics. The Companys portfolio includes compounds in various ...See Company Profile ...Dividend History.$78.97$57$89.3
7.BioMarin Pharmaceutical (BMRN)$13.43 billion-15.53%BioMarin Pharmaceutical Inc., incorporated on October 25, 1996, is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the ...See Company Profile ...Dividend History.$71.93$71.19$106.74
8.Seattle Genetics (SGEN)$10.96 billion19.64%Seattle Genetics, Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-d...See Company Profile ...Dividend History.$67.79$50.71$84.37
9.Array BioPharma (ARRY)$10.68 billion235.79%Array BioPharma Inc. (Array), incorporated on February 6, 1998, is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with ...See Company Profile ...Dividend History.$47.85$12.56$47.98
10.Galapagos NV (GLPG)$10.17 billion71.65%Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes novel medicines. Its clinical stage programs include filgotinib, which is in Phase III clinical trials for...See Company Profile ...Dividend History.$157.47$85$191.63
11.Alnylam Pharma (ALNY)$9.3 billion13.41%Alnylam Pharmaceuticals, Inc., incorporated on May 8, 2003, is a biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The ...See Company Profile ...Dividend History.$82.69$60.27$110
12.Neurocrine Biosciences (NBIX)$9.2 billion40.04%Neurocrine Biosciences, Inc., incorporated on March 20, 1996, is engaged in discovering and developing pharmaceuticals, in diseases with unmet medical needs, through its research and development (R&D) platform, focused on ...See Company Profile ...Dividend History.$100$64.72$126.98
13.BeiGene (BGNE)$8.96 billion-10.56%BeiGene, Ltd. is a clinical-stage biopharmaceutical company. The Company is focused in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The Company had ...See Company Profile ...Dividend History.$125.45$105.19$179.57
14.Ionis Pharma (IONS)$8.65 billion11.21%Ionis Pharmaceuticals, Inc., incorporated on March 25, 1991, is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company, using its drug discovery platform, has developed a pipeline of ...See Company Profile ...Dividend History.$60.12$43.27$86.58
15.Sage Therapeutics (SAGE)$7.79 billion57.34%SAGE Therapeutics, Inc., incorporated on April 16, 2010, is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The ...See Company Profile ...Dividend History.$150.72$79.88$193.56
16.Jazz Pharma (JAZZ)$7.19 billion1.07%Jazz Pharmaceuticals Public Limited Company, incorporated on March 15, 2005, is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company ...See Company Profile ...Dividend History.$125.29$113.52$169.82
17.Bio-Techne (TECH)$6.95 billion26.84%Bio-Techne Corporation, incorporated on July 17, 1981, develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through three segments: Biotechnology, Clinical ...See Company Profile ...Dividend History.$183.56$132.75$217.16
18.Sarepta Therapeutics (SRPT)$6.78 billion-20.61%Sarepta Therapeutics, Inc., incorporated on June 5, 2013, is a biopharmaceutical company. The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of ...See Company Profile ...Dividend History.$86.64$83.63$165.87
19.ACADIA Pharma (ACAD)$6.52 billion140.26%ACADIA Pharmaceuticals Inc., incorporated on January 16, 1997, is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. The ...See Company Profile ...Dividend History.$38.85$13.17$43.98
20.Exelixis (EXEL)$5.93 billion-3.41%Exelixis, Inc., incorporated on November 15, 1994, is a biopharmaceutical company. The Company is focused on discovery, development and commercialization of new medicines to manage care and outcomes for people ...See Company Profile ...Dividend History.$19$13.42$25.31
21.bluebird bio (BLUE)$5.72 billion0.45%bluebird bio, Inc., incorporated on April 16, 1992, is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene ...See Company Profile ...Dividend History.$99.65$87.49$163.43
22.Moderna (MRNA)$5.24 billion4.91%Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic va...See Company Profile ...Dividend History.$16.03$11.54$29.79
23.Amarin (AMRN)$5.23 billion16.68%Amarin Corporation plc, incorporated on March 1, 1989, is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company ...See Company Profile ...Dividend History.$15.88$2.65$23.91
24.Ascendis Pharma AS (ASND)$5.06 billion69.48%Ascendis Pharma A/S, incorporated on September 21, 2006, is a clinical-stage biopharmaceutical company. The Company is engaged in applying its TransCon technology to develop sustained release prodrug therapies with several ...See Company Profile ...Dividend History.$106.18$53.21$133.96
25.argenx SE (ARGX)$4.9 billion28.09%argenx SE, a clinical-stage biopharmaceutical company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's lead product candidates include ARGX-113 ...See Company Profile ...Dividend History.$129$63.81$150.92
26.Repligen (RGEN)$4.24 billion55.82%Repligen Corporation, incorporated on May 29, 1981, is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of ...See Company Profile ...Dividend History.$82.18$48.26$99.25
27.Allakos (ALLK)$3.93 billion49.75%Allakos Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases. The company is developing AK002 for the treat...See Company Profile ...Dividend History.$78.26$29.34$92.84
28.China Biologic Products (CBPO)$3.79 billion33.13%China Biologic Products, Inc. (China Biologic), incorporated on January 10, 2007, is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based ...See Company Profile ...Dividend History.$101.06$60.08$103.5
29.FibroGen (FGEN)$3.78 billion-12.4%FibroGen, Inc., incorporated on September 29, 1993, is a science-based biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapeutics to treat serious unmet medical needs. ...See Company Profile ...Dividend History.$40.54$33.51$61.95
30.Spark Therapeutics (ONCE)$3.73 billion156.95%Spark Therapeutics, Inc. (Spark), incorporated on March 13, 2013, is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple ...See Company Profile ...Dividend History.$100.57$34.53$114.2
31.MorphoSys AG (MOR)$3.7 billion11.96%MorphoSys AG, together with its subsidiaries, engages in the research, development, and optimization of therapeutic antibody drug candidates in partnership with pharmaceutical and biotechnology companies. The c...See Company Profile ...Dividend History.$29.01$21.75$31.96
32.Blueprint Medicines (BPMC)$3.53 billion35.73%Blueprint Medicines Corporation, incorporated on October 14, 2008, is a biopharmaceutical company. The Company focuses on patients with genomically defined diseases driven by abnormal kinase activation. The Company focuses on ...See Company Profile ...Dividend History.$73.17$44.58$102.98
33.United Therapeutics (UTHR)$3.51 billion-26.45%United Therapeutics Corporation, incorporated on June 26, 1996, is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening ...See Company Profile ...Dividend History.$80.1$74.31$129.59
34.Allogene Therapeutics (ALLO)$3.44 billion6.05%Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the research, development, and commercialization of genetically engineered allogeneic T cell therapies for the treatment of canc...See Company Profile ...Dividend History.$28.58$21.67$35.55
35.Alkermes (ALKS)$3.37 billion-29.85%Alkermes plc, incorporated on May 4, 2011, is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs ...See Company Profile ...Dividend History.$20.7$19.36$45.16
36.Nektar Therapeutics (NKTR)$3.23 billion-45.66%Nektar Therapeutics, incorporated on June 3, 1998, is a biopharmaceutical company that discovers and develops medicines in areas of high unmet medical need. The Companys research and development pipeline of ...See Company Profile ...Dividend History.$17.86$16.56$66.55
37.Mirati Therapeutics (MRTX)$3.05 billion94.96%Mirati Therapeutics, Inc., incorporated on April 29, 2013, is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of targeted oncology products. The Companys clinical pipeline consists ...See Company Profile ...Dividend History.$82.7$28.5$111.99
38.Ultragenyx Pharmaceutical (RARE)$2.99 billion-1.91%Ultragenyx Pharmaceutical Inc., incorporated on June 13, 2011, is a clinical-stage biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of products for the treatment of ...See Company Profile ...Dividend History.$42.65$37.44$90.98
39.Arrowhead Pharma (ARWR)$2.97 billion131.08%Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, incorporated on February 13, 2001, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic ...See Company Profile ...Dividend History.$28.7$10.41$36.8
40.Global Blood Therapeutics (GBT)$2.78 billion23.51%Global Blood Therapeutics, Inc., incorporated on February 04, 2011, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics to treat blood-based disorders. The Company ...See Company Profile ...Dividend History.$50.7$30.15$64.94
41.Amicus Therapeutics (FOLD)$2.59 billion-0.84%Amicus Therapeutics, Inc., incorporated on February 4, 2002, is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living ...See Company Profile ...Dividend History.$9.5$8.27$14.62
42.Arena Pharma (ARNA)$2.55 billion28.83%Arena Pharmaceuticals, Inc., incorporated on April 14, 1997, is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has ...See Company Profile ...Dividend History.$50.18$31.97$64.48
43.PTC Therapeutics (PTCT)$2.53 billion24.8%PTC Therapeutics, Inc., incorporated on March 31, 1998, is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicines using its expertise in ribonucleic acid ...See Company Profile ...Dividend History.$42.83$27.53$48.99
44.CRISPR Therapeutics AG (CRSP)$2.51 billion59.01%Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 ...See Company Profile ...Dividend History.$45.43$22.22$56.13
45.Iovance Biotherapeutics (IOVA)$2.48 billion125.68%Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate canc...See Company Profile ...Dividend History.$19.95$7.26$26.59
46.Immunomedics (IMMU)$2.47 billion-6.94%Immunomedics, Inc., incorporated on July 6, 1982, is a clinical-stage biopharmaceutical company, which is engaged in researching, developing, manufacturing and marketing biopharmaceutical products. It develops monoclonal antibody-based products for the ...See Company Profile ...Dividend History.$13.28$11.55$24.99
47.MyoKardia (MYOK)$2.47 billion6.61%MyoKardia, Inc., incorporated on June 8, 2012, is a clinical-stage biopharmaceutical company. The Company focuses on the treatment of heritable cardiomyopathies, a group of rare, genetically-driven forms of heart failure ...See Company Profile ...Dividend History.$52.09$39.01$67.79
48.Acceleron Pharma (XLRN)$2.42 billion4.48%Acceleron Pharma Inc., incorporated on June 13, 2003, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics to treat serious and rare ...See Company Profile ...Dividend History.$45.5$37.01$59.59
49.Reata Pharma (RETA)$2.41 billion59.38%Reata Pharmaceuticals, Inc., incorporated on March 11, 2002, is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of regulatory ...See Company Profile ...Dividend History.$89.41$47.5$104.53
50.Halozyme Therapeutics (HALO)$2.41 billion8.48%Halozyme Therapeutics, Inc., incorporated on August 23, 2007, is a biotechnology company focused on developing and commercializing oncology therapies. The Company operates in research, development and commercialization of human enzymes ...See Company Profile ...Dividend History.$15.87$13.24$18.76
51.Zai Lab (ZLAB)$2.39 billion52.89%Zai Lab Limited, a biopharmaceutical company, engages in discovering or licensing, developing, and commercializing proprietary therapeutics that address medical needs in the fields of oncology, and autoimmune and infectious disease therapies in the People's Republic of China. Its drug candidates include ZL-2306, a poly ADP ribose polymerase 1 002F2 inhibitor, ...See Company Profile ...Dividend History.$35.5$14.29$38.44
52.Emergent Biosolutions (EBS)$2.28 billion-4.47%Emergent BioSolutions Inc., incorporated on December 19, 2003, is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations ...See Company Profile ...Dividend History.$56.63$39.11$73.89
53.Agios Pharma (AGIO)$2.18 billion-27.35%Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a clinical-stage biopharmaceutical company. The Companys therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group ...See Company Profile ...Dividend History.$33.5$33.17$79.17
54.Intercept Pharma (ICPT)$2.16 billion-36.05%Intercept Pharmaceuticals, Inc., incorporated on September 4, 2002, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The ...See Company Profile ...Dividend History.$64.46$58.21$133.74
55.uniQure (QURE)$2.11 billion58.61%uniQure N.V. (uniQure) is a gene therapy company. The Company is engaged in developing single treatments with curative results for patients suffering from genetic and other severe diseases. The Company ...See Company Profile ...Dividend History.$45.71$21.98$82.49
56.Biohaven Pharmaceutical Holding Company (BHVN)$2.03 billion11.82%Biohaven Pharmaceutical Holding Company Ltd., a clinical-stage biopharmaceutical company, develops product candidates to treat neurological diseases, including rare disorders. Its lead product candidate is rime...See Company Profile ...Dividend History.$41.24$29.17$67.86
57.Akcea Therapeutics (AKCA)$2.02 billion-33.72%Akcea Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with cardiometabolic diseases caused by lipid disorders in the United States a...See Company Profile ...Dividend History.$19.99$18.68$37.73
58.Cambrex (CBM)$2.01 billion58.63%Cambrex Corporation (Cambrex), incorporated on October 11, 1983, is a life sciences company. The Company provides products and services for the development and commercialization of generic therapeutics. Cambrex operates through ...See Company Profile ...Dividend History.$59.9$33.8$69.43
59.Xencor (XNCR)$1.97 billion-3.82%Xencor, Inc., incorporated on June 8, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing engineered monoclonal antibodies to treat severe and life threatening diseases. ...See Company Profile ...Dividend History.$34.78$27.75$48.38
60.Portola Pharma (PTLA)$1.93 billion41.85%Portola Pharmaceuticals, Inc., incorporated on September 2, 2003, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics in the areas of thrombosis, other hematologic ...See Company Profile ...Dividend History.$27.69$14.81$37.95
61.Apellis Pharmaceuticals (APLS)$1.85 billion142.84%Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutic compounds for autoimmune and inflammatory diseases. Its lead product candidate is APL-2...See Company Profile ...Dividend History.$32.03$11.45$33.18
62.Denali Therapeutics (DNLI)$1.8 billion-11.64%Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company offers leucine-rich repeat kinase 2 (LRRK2) ...See Company Profile ...Dividend History.$18.3$13.78$28.86
63.Ligand Pharma (LGND)$1.7 billion-36.44%Ligand Pharmaceuticals Incorporated (Ligand), incorporated on September 28, 1987, is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company ...See Company Profile ...Dividend History.$86.25$85.87$278.62
64.Deciphera Pharmaceuticals (DCPH)$1.69 billion68.66%Deciphera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durabi...See Company Profile ...Dividend History.$35.3$18.55$42.99
65.Eidos Therapeutics (EIDX)$1.55 billion206.98%Eidos Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drugs to treat diseases caused by transthyretin (TTR) amyloidosis (ATTR). It is developing AG10, an orally-administere...See Company Profile ...Dividend History.$42.24$8.89$46.44
66.Insmed (INSM)$1.55 billion37.04%Insmed Incorporated, incorporated on March 21, 2013, is a biopharmaceutical company. The Company operates through development and commercialization of therapies for patients with rare diseases segment. The Companys lead product ...See Company Profile ...Dividend History.$17.98$11.31$33.13
67.Coherus BioSciences (CHRS)$1.49 billion117.68%Coherus BioSciences, Inc., incorporated on September 29, 2010, is a late-stage clinical biologics platform company. The Company is engaged in the business of developing and commercializing biosimilar products. The Companys ...See Company Profile ...Dividend History.$19.7$8.32$23.43
68.Madrigal Pharma (MDGL)$1.44 billion-13.12%Madrigal Pharmaceuticals, Inc., formerly Synta Pharmaceuticals Corp., incorporated on March 10, 2000, is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapeutic candidates for the ...See Company Profile ...Dividend History.$97.93$82.39$240.23
69.Audentes Therapeutics (BOLD)$1.42 billion43.71%Audentes Therapeutics, Inc., incorporated on November 13, 2012, is an early-stage biotechnology company. The Company is focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening ...See Company Profile ...Dividend History.$30.64$17.95$41.65
70.Corcept Therapeutics (CORT)$1.42 billion-5.99%Corcept Therapeutics Incorporated, incorporated on May 13, 1998, is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic ...See Company Profile ...Dividend History.$12.56$9.14$19.48
71.Orchard Therapeutics (ORTX)$1.42 billion5.93%Orchard Therapeutics plc, integrated biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases. The company's gene therapy approach seeks to transform a patient's hematop...See Company Profile ...Dividend History.$16.62$8.65$21.64
72.Enanta Pharma (ENTA)$1.36 billion-7.38%Enanta Pharmaceuticals, Inc., incorporated on July 25, 1995, is a research and development-focused biotechnology company. The Company uses chemistry-driven approach and drug discovery solutions to create small molecule drugs for ...See Company Profile ...Dividend History.$65.6$64.08$106.8
73.G1 Therapeutics (GTHX)$1.35 billion88.2%G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel small molecule therapeutics for the treatment of patients with cancer in ...See Company Profile ...Dividend History.$36.04$13.87$69.57
74.Theravance Biopharma (TBPH)$1.27 billion-14.65%Theravance Biopharma, Inc. (Theravance Biopharma) is a biopharmaceutical company. The Company is engaged in creating medicines for patients suffering from serious illness. The Company operates in the segment of discovery ...See Company Profile ...Dividend History.$21.84$15.18$35.48
75.Veracyte (VCYT)$1.25 billion98.09%Veracyte, Inc., incorporated on August 15, 2006, is a genomic diagnostics company. The Company uses genomic technology to resolve diagnostic ambiguity. The Company targets diseases in which patients undergo invasive ...See Company Profile ...Dividend History.$24.92$8.77$31.18
76.Sangamo Therapeutics (SGMO)$1.23 billion-9.49%Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc., incorporated on June 22, 1995, is a clinical-stage biotechnology company. The Company is focused on translating science into genomic therapies that transform patients ...See Company Profile ...Dividend History.$10.39$6.26$17.35
77.Aimmune Therapeutics (AIMT)$1.23 billion-17.35%Aimmune Therapeutics, Inc., incorporated on June 24, 2011, is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other ...See Company Profile ...Dividend History.$19.77$16.95$36.12
78.Editas Medicine (EDIT)$1.22 billion6.73%Editas Medicine, Inc., incorporated on September 3, 2013, is a genome editing company. The Company is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. The ...See Company Profile ...Dividend History.$24.28$17.8$33.8
79.Innoviva (INVA)$1.2 billion-34.27%Innoviva, Inc., formerly Theravance, Inc., incorporated on November 19, 1996, focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization ...See Company Profile ...Dividend History.$11.47$10.76$20.54
80.Epizyme (EPZM)$1.19 billion112.99%Epizyme, Inc., incorporated on November 1, 2007, is a clinical-stage biopharmaceutical company. The Company discovers, develops and plans to commercialize epigenetic therapies for cancer patients. The Company is engaged in ...See Company Profile ...Dividend History.$13.12$5.14$16.59
81.Ra Pharma (RARX)$1.18 billion37.91%Ra Pharmaceuticals, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company focuses on the development of therapeutics for diseases of complement dysregulation and a range of orphan indications. It ...See Company Profile ...Dividend History.$25.1$11.27$36.96
82.REGENXBIO (RGNX)$1.18 billion-23.55%REGENXBIO Inc., incorporated on July 16, 2008, is a clinical-stage biotechnology company. The Companys gene therapy product candidates are designed to deliver genes to cells to address genetic defects or ...See Company Profile ...Dividend History.$32.07$30.38$83.45
83.Athenex (ATNX)$1.12 billion8.12%Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of various therapies for the treatment of cancer and related conditions. The company's Orascovery product...See Company Profile ...Dividend History.$13.72$9.38$21.11
84.AnaptysBio (ANAB)$1.12 billion-34.77%AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing antibody product candidates focused on unmet medical needs in inflammation. The company's proprietary anti-inflammatory pipeline i...See Company Profile ...Dividend History.$41.69$38.53$110
85.Cara Therapeutics (CARA)$1.06 billion75.54%Cara Therapeutics, Inc., incorporated on July 2, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by ...See Company Profile ...Dividend History.$22.82$12.19$27.55
86.Fate Therapeutics (FATE)$1.05 billion37.02%Fate Therapeutics, Inc. (Fate Therapeutics), incorporated on April 27, 2007, is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. ...See Company Profile ...Dividend History.$17.58$11$22.82
87.Zymeworks (ZYME)$1.05 billion96.73%Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The company's lead product candidate is ZW25, a novel bispecific antibody that is in Phase I clinical trial for the treatment of breast and gastric cancer. It is ...See Company Profile ...Dividend History.$28.88$10.72$29.75
88.Esperion Therapeutics (ESPR)$1.01 billion-23.17%Esperion Therapeutics, Inc., incorporated on January 22, 2008, is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the ...See Company Profile ...Dividend History.$35.34$33.13$60.99
89.Odonate Therapeutics (ODT)$1 billion117.21%Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It focuses on the development of tesetaxel, an orally administered chemotherapy agent for patients with a...See Company Profile ...Dividend History.$30.67$11.54$43.75
90.Intrexon (XON)$959.68 million-11.01%Intrexon Corporation (Intrexon), incorporated on May 21, 2014, forms collaborations to create biologically-based products and processes using synthetic biology. The Companys domestic operations are in California, Florida, Maryland, and Virginia, ...See Company Profile ...Dividend History.$5.82$3.95$19.94
91.Y-mAbs Therapeutics (YMAB)$954 million37.17%Y-mAbs Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody therapeutic products for cancer treatment in the United States. It is developing naxitamab for the treatment of pediatric patients with relapsed or refractory, high-risk neuroblastoma, as well as other GD2 positive tumors; and omburtamab ...See Company Profile ...Dividend History.$27.9$15.17$31
92.Dicerna Pharma (DRNA)$948.86 million31.52%Dicerna Pharmaceuticals, Inc., incorporated on October 24, 2006, is a ribonucleic acid (RNA) interference-based biopharmaceutical company. The Company operates in the segment of discovery, research and development of treatments based ...See Company Profile ...Dividend History.$14.06$9.31$17.98
93.ArQule (ARQL)$936.48 million192.42%ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. It offers Derazantinib (ARQ 087), a multi-kinase inh...See Company Profile ...Dividend History.$8.1$2.23$12.22
94.Principia Biopharma (PRNB)$914.49 million31.22%Principia Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on developing novel oral therapies for immunology and oncology in the United States. It is developing PRN1008, an inhibitor that is ...See Company Profile ...Dividend History.$35.94$22$42.34
95.Omeros (OMER)$892.8 million60.05%Omeros Corporation, incorporated on June 16, 1994, is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market, as well as orphan ...See Company Profile ...Dividend History.$17.83$10.3$27
96.Homology Medicines (FIXX)$866.37 million-5.81%Homology Medicines, Inc., a genetic medicines company, focuses on translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Its proprietary platfo...See Company Profile ...Dividend History.$21.06$14.19$31.8
97.Axsome Therapeutics (AXSM)$855.8 million758.51%Axsome Therapeutics, Inc., incorporated on January 12, 2012, is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders, including ...See Company Profile ...Dividend History.$24.21$1.94$28.7
98.Bavarian Nordic ADR (BVNRY)$854.02 million11.25%Bavarian Nordic A S, a biotechnology company, develops, manufactures, and commercializes a portfolio of novel vaccines for the prevention and treatment of life-threatening infectious diseases and cancer. T...See Company Profile ...Dividend History.$8.7$5.92$9.55
99.Arvinas Holding Co (ARVN)$852.39 million80.7%Arvinas Holding Company, LLC, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110, prote...See Company Profile ...Dividend History.$23.22$10.19$28.25
100.Nightstar Therapeutics (NITE)$852.16 million120.57%Nightstar Therapeutics plc, a clinical-stage gene therapy company, focuses on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases in the United K...See Company Profile ...Dividend History.$25.41$9.59$29.55
101.NanoString (NSTG)$837.33 million55.36%NanoString Technologies, Inc., incorporated on June 20, 2003, develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company ...See Company Profile ...Dividend History.$23.04$13.26$34.78
102.Spectrum Pharma (SPPI)$832.75 million-13.26%Spectrum Pharmaceuticals, Inc., incorporated on November 18, 2002, is a biotechnology company. The Company operates through developing and commercializing oncology and hematology drug products segment. It has a product portfolio ...See Company Profile ...Dividend History.$7.59$6.22$21.8
103.Rhythm Pharmaceuticals (RYTM)$812.52 million-20.24%Rhythm Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of peptide therapeutics for the treatment of rare genetic disorders of obesity in the United States. Its peptide candidates include Setmelanotide, a melanocortin-4 receptor agonist, which is in Phase III clinical trial to treat POMC and leptin receptor ...See Company Profile ...Dividend History.$21.44$18$32.62
104.ANI Pharma (ANIP)$809.37 million48%ANI Pharmaceuticals, Inc., incorporated on April 11, 2001, is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company ...See Company Profile ...Dividend History.$66.63$36.92$86.96
105.Codexis (CDXS)$803.23 million-19.52%Codexis, Inc., incorporated on January 31, 2002, is a developer of biocatalysts for the pharmaceutical and fine chemicals markets. The Companys technologies enable scale-up and implementation of biocatalytic solutions for ...See Company Profile ...Dividend History.$13.44$12.68$23.05
106.WAVE Life Sciences (WVE)$793 million-50.17%WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for ...See Company Profile ...Dividend History.$20.95$18.16$56
107.Anika Therapeutics (ANIK)$780.9 million63.94%Anika Therapeutics, Inc., incorporated on February 28, 1992, is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. ...See Company Profile ...Dividend History.$55.1$29.01$58.93
108.Atara Biotherapeutics (ATRA)$764.09 million-57.57%Atara Biotherapeutics, Inc., incorporated on August 22, 2012, is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with severe and life-threatening diseases. The Company operates ...See Company Profile ...Dividend History.$14.74$11.89$43.95
109.Krystal Biotech (KRYS)$753 million98.85%Krystal Biotech, Inc., a gene therapy company, develops and commercializes pharmaceutical products for patients suffering from dermatological diseases in the United States. The company's lead product candidate ...See Company Profile ...Dividend History.$41.32$14.3$51.67
110.ZIOPHARM Oncology (ZIOP)$749.37 million146.52%ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of immuno-oncology therapies for treating heterogenous solid tumors and unknown anti...See Company Profile ...Dividend History.$4.61$1.56$7.25
111.Rubius Therapeutics (RUBY)$745.45 million-40.8%Rubius Therapeutics, Inc. focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases through its rubius erythrocyte design cellular therapy platform. The company is developing various RCTs, such as RTX-134 for treatment of classic and moderate phenylketonuria; RTX-Uricase 002FURAT1 for treatment of chronic ...See Company Profile ...Dividend History.$9.49$8.67$24.49
112.Alder BioPharma (ALDR)$743.39 million-15.8%Alder BioPharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize genetically engineered therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alders lead ...See Company Profile ...Dividend History.$8.63$8.39$18.95
113.Cytokinetics (CYTK)$741.35 million100.47%Cytokinetics, Incorporated, incorporated on August 5, 1997, is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases ...See Company Profile ...Dividend History.$12.67$5.75$14.94
114.Cerus (CERS)$740.1 million-2.17%Cerus Corporation, incorporated on July 31, 1996, is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates ...See Company Profile ...Dividend History.$4.96$4.49$7.54
115.Vanda Pharma (VNDA)$739.01 million-48.87%Vanda Pharmaceuticals Inc., incorporated on November 13, 2002, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies to address unmet medical needs. Its product ...See Company Profile ...Dividend History.$13.36$11.83$33.44
116.MeiraGTx (MGTX)$730.73 million101.14%MeiraGTx Holdings plc, an integrated clinical stage gene therapy company, develops various gene therapy products for the lives of patients suffering from acquired and inherited disorders. The company focuses on...See Company Profile ...Dividend History.$19.39$8.53$30.23
117.Vericel (VCEL)$718.26 million-8.74%Vericel Corporation (Vericel), formerly Aastrom Biosciences, Inc., incorporated on March 24, 1989, is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body ...See Company Profile ...Dividend History.$15.88$10.51$21.01
118.UroGen Pharma (URGN)$714.16 million-22.04%UroGen Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing novel therapies for urological pathologies. Its lead product candidates, MitoGel and VesiGel are proprietary formulations of the chemotherapy drug Mitomycin C, a generic drug, which is currently used off-label for urothelial cancer treatment in a water-based formulation as an ...See Company Profile ...Dividend History.$33.57$30.48$55.49
119.MacroGenics (MGNX)$706.93 million5.67%MacroGenics, Inc., incorporated on August 14, 2000, is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune ...See Company Profile ...Dividend History.$13.42$9.87$32.32
120.Intellia Therapeutics (NTLA)$691.35 million0.22%Intellia Therapeutics, Inc., incorporated on May 7, 2014, is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome ...See Company Profile ...Dividend History.$13.68$11.03$32.95
121.Kura Oncology (KURA)$686.36 million10.61%Kura Oncology, Inc., incorporated on November 16, 2007, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and ...See Company Profile ...Dividend History.$15.53$10.2$21.42
122.Adverum Biotechnologies (ADVM)$683.99 million295.24%Adverum Biotechnologies, Inc., formerly Avalanche Biotechnologies, Inc., incorporated on July 17, 2006, is a gene therapy company. The Company is engaged in discovering and developing medicines to patients suffering from ...See Company Profile ...Dividend History.$12.45$2.62$16.38
123.Myovant Sciences (MYOV)$665.05 million-57.71%Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for women?ÇÖs health diseases and other endocrine-related disorders. Its main product candidate is Relugolix. Relugolix is ...See Company Profile ...Dividend History.$6.94$6.6$27.45
124.Zealand Pharma (ZEAL)$617.76 million104.46%Zealand Pharma A 002FS, a biotechnology company, engages in the discovery, design, and development of peptide therapeutics-based medicines in Denmark. It has a portfolio of proprietary medicines in late-stage clinical development focusing on gastrointestinal and metabolic diseases. The company markets lixisenatide for the treatment of type 2 diabetes under the ...See Company Profile ...Dividend History.$23.82$11.51$23.82
125.DBV (DBVT)$616.92 million47.82%DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy ...See Company Profile ...Dividend History.$9.49$3.6$25.77
126.AVROBIO (AVRO)$613.57 million25.35%AVROBIO, Inc., a clinical stage gene therapy company, focuses on developing ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. The company's gene therapies employ hematopoie...See Company Profile ...Dividend History.$20.87$11.85$53.7
127.Voyager Therapeutics (VYGR)$610.89 million75.96%Voyager Therapeutics, Inc., incorporated on June 19, 2013, is a clinical-stage gene therapy company. The Company focuses on developing treatments for patients suffering from severe diseases of the central nervous ...See Company Profile ...Dividend History.$16.54$7.76$28.79
128.TG Therapeutics (TGTX)$598.67 million56.83%TG Therapeutics, Inc. (TG), incorporated on May 18, 1993, is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of ...See Company Profile ...Dividend History.$6.43$3.32$11.9
129.Achillion Pharma (ACHN)$587.79 million160.38%Achillion Pharmaceuticals, Inc., incorporated on August 5, 1998, is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and ...See Company Profile ...Dividend History.$4.14$1.29$5.03
130.China Cord Blood (CO)$584.43 million-34.88%Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, pr...See Company Profile ...Dividend History.$4.2$4.14$7.73
131.Rocket Pharmaceuticals (RCKT)$581.92 million-16.26%Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating pediatric diseases. It has two lentiviral vector (LVV) programs under clinical testing to treat fanconi anemia, a genetic defect in the bone marrow that reduces production of ...See Company Profile ...Dividend History.$12.41$10.75$25.96
132.Quanterix (QTRX)$581.03 million26.49%Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Euro...See Company Profile ...Dividend History.$23.16$14.75$36.15
133.Synthorx (THOR)$580.14 million3.45%Synthorx, Inc., a biotechnology company, discovers and develops protein therapeutics. The company's lead product candidate is THOR-707, a variant of IL-2 that is in development in various tumor types as a singl...See Company Profile ...Dividend History.$17.98$11$23.53
134.Aurinia Pharma (AUPH)$523.57 million-14.96%Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Companys primary business is the development of a therapeutic drug to treat ...See Company Profile ...Dividend History.$5.8$5.06$7.85
135.Akebia Therapeutics (AKBA)$516.24 million-22.6%Akebia Therapeutics, Inc., incorporated on February 27, 2007, is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology. The Companys ...See Company Profile ...Dividend History.$4.28$3.5$10.45
136.Viking Therapeutics (VKTX)$511.03 million-5.23%Viking Therapeutics, Inc., incorporated on October 24, 2012, is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapies for metabolic and endocrine disorders. The Companys clinical program, ...See Company Profile ...Dividend History.$7.25$6.53$24
137.Transgenomic (TBIO)$509.08 million33.07%Transgenomic, Inc. (Transgenomic), incorporated on March 6, 1997, is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases ...See Company Profile ...Dividend History.$9.98$4.81$14.34
138.Intra-Cellular Therapies (ITCI)$508.2 million-9.31%Intra-Cellular Therapies, Inc. (ITI), incorporated on August 29, 2012, is a biopharmaceutical company. The Company is focused on the discovery and clinical development of small molecule drugs that address underserved ...See Company Profile ...Dividend History.$10.33$7.41$23.62
139.Kiniksa Pharmaceuticals (KNSA)$502.55 million-65.5%Kiniksa Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company, focuses on the discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating d...See Company Profile ...Dividend History.$9.69$8.04$32.88
140.Cellectis (CLLS)$500.05 million-28.47%Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development and commercialization of rational genome engineering technologies. ...See Company Profile ...Dividend History.$11.91$11.53$29.4
141.Aptorum Group (APM)$498.42 million8.7%Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and ...See Company Profile ...Dividend History.$16.5$11.8$33.28
142.Stemline Therapeutics (STML)$497.58 million19.16%Stemline Therapeutics, Inc., incorporated on August 8, 2003, is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing oncology therapeutics. The Company is developing approximately three clinical stage ...See Company Profile ...Dividend History.$11.32$7.82$18.22
143.Revance Therapeutics (RVNC)$497.04 million-44.01%Revance Therapeutics, Inc., incorporated on August 10, 1999, is a clinical-stage biotechnology company. The Company is focused on the development, manufacturing and commercialization of botulinum toxin products for multiple aesthetic ...See Company Profile ...Dividend History.$11.27$9.88$27.45
144.Syros Pharma (SYRS)$486.86 million80.43%Syros Pharmaceuticals, Inc., incorporated on November 9, 2011, is a biopharmaceutical company. The Company offers a gene control platform designed to analyze the unexploited region of deoxyribonucleic acid (DNA) in ...See Company Profile ...Dividend History.$10.05$5.17$13.16
145.Mesoblast (MESO)$477.56 million22.09%Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish ...See Company Profile ...Dividend History.$5.03$3.35$8.78
146.Autolus Therapeutics (AUTL)$473.16 million-56.33%Autolus Therapeutics plc, a biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company is developing AUTO1, a CD19-targeting programmed T cell therapy, which is in Phase I tri...See Company Profile ...Dividend History.$14.32$9.5$53.24
147.Sinovac Biotech (SVA)$460.25 million-6.77%Sinovac Biotech Ltd. (Sinovac), incorporated on March 1, 1999, is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines ...See Company Profile ...Dividend History.$6.47$6.25$6.58
148.Dermira (DERM)$442.05 million16.69%Dermira, Inc., incorporated on August 18, 2010, is a biopharmaceutical company. As of December 31, 2016, the Companys portfolio included three late-stage product candidates that target unmet needs and market ...See Company Profile ...Dividend History.$8.39$6$15.48
149.Protagonist Therapeutics (PTGX)$435.2 million146.06%Protagonist Therapeutics, Inc., incorporated on August 22, 2006, is a clinical-stage biopharmaceutical company with a peptide technology platform focused on discovering and developing new chemical entities (NECs) to address significant ...See Company Profile ...Dividend History.$16.56$5.49$16.66
150.SIGA Technologies (SIGA)$427.12 million-33.29%SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatmen...See Company Profile ...Dividend History.$5.27$4.68$8.09
151.ObsEva SA (OBSV)$422.12 million-26.15%ObsEva SA, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy disorders. It is developi...See Company Profile ...Dividend History.$9.35$8.22$19.4
152.Puma Biotechnology (PBYI)$421.25 million-46.73%Puma Biotechnology, Inc., incorporated on September 15, 2010, is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of cancer. The Company focuses on ...See Company Profile ...Dividend History.$10.84$8.45$50.75
153.Dova Pharmaceuticals (DOVA)$421.25 million90.77%Dova Pharmaceuticals, Inc., a pharmaceutical company, focuses on acquiring, developing, and commercializing drug candidates for thrombocytopenia disease. The company's lead drug candidate is avatrombopag that h...See Company Profile ...Dividend History.$14.46$5.62$25.09
154.Kodiak Sciences (KOD)$420.25 million73.16%Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat ophthalmic diseases. The company's lead product candidate is KSI-301, a vascular endothelial growth factor ...See Company Profile ...Dividend History.$12$5.65$15.22
155.ImmunoGen (IMGN)$417.74 million-39.38%ImmunoGen, Inc., incorporated on March 27, 1981, is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its antibody-drug conjugate (ADC) technology. The Company is engaged in the discovery ...See Company Profile ...Dividend History.$2.91$1.76$9.84
156.CytomX Therapeutics (CTMX)$414.61 million-41.32%CytomX Therapeutics, Inc., incorporated on September 16, 2010, is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as ...See Company Profile ...Dividend History.$8.86$8.07$22.5
157.CymaBay Therapeutics (CBAY)$414.24 million-23.13%CymaBay Therapeutics, Inc., incorporated on October 5, 1988, is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. ...See Company Profile ...Dividend History.$6.05$4.82$14
158.BioSpecifics (BSTC)$412.19 million-9.64%BioSpecifics Technologies Corp. (BioSpecifics), incorporated on November 1, 1990, is a biopharmaceutical company. The Company is engaged in the development of an injectable collagenase clostridium histolyticum (CCH) for multiple indications. ...See Company Profile ...Dividend History.$54.76$52.03$73.31
159.ChemoCentryx (CCXI)$407.17 million-34.01%ChemoCentryx, Inc., incorporated on November 8, 1996, is a biopharmaceutical company. The Company is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of the ...See Company Profile ...Dividend History.$7.2$6.16$14.98
160.Agenus (AGEN)$400.56 million31.93%Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. The company offers Retrocyte Display,...See Company Profile ...Dividend History.$3.14$1.54$3.88
161.Crinetics Pharmaceuticals (CRNX)$396.34 million-43.05%Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. I...See Company Profile ...Dividend History.$17.08$15.5$38.51
162.Progenics Pharma (PGNX)$393.61 million19.29%Progenics Pharmaceuticals, Inc., incorporated on December 1, 1986, is engaged in developing medicines and other products for targeting and treating cancer. The Companys pipeline includes therapeutic agents designed to target ...See Company Profile ...Dividend History.$5.01$3.42$7.49
163.BioDelivery Sciences Intl (BDSI)$386.68 million19.46%BioDelivery Sciences International, Inc., incorporated on April 18, 2002, is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications ...See Company Profile ...Dividend History.$4.42$2.55$5.37
164.Magenta Therapeutics (MGTA)$383 million73.16%Magenta Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing medicines to bring the curative power of bone marrow transplant to patients. It is developing C100, C200, and C300 t...See Company Profile ...Dividend History.$9.87$5.31$21
165.BeyondSpring (BYSI)$382.46 million2.35%BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies. The company is advancing its lead asset, Plinabulin, into a Phase 2 3 clinical trial for the r...See Company Profile ...Dividend History.$19.19$13.06$26.98
166.MediciNova (MNOV)$380.59 million9.3%MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is dev...See Company Profile ...Dividend History.$8.93$6.68$13.37
167.Merus (MRUS)$376.58 million17.86%Merus NV is a biotechnology company based in the Netherlands. The Company develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics ...See Company Profile ...Dividend History.$16.5$11$21
168.AMAG Pharma (AMAG)$376.21 million-21.72%AMAG Pharmaceuticals, Inc., incorporated on November 9, 1981, is a pharmaceutical company. The Companys segment is the manufacture, development and commercialization of products and services for use in treating various ...See Company Profile ...Dividend History.$11.89$6.81$24.65
169.Avid Bioservices (CDMO)$372.32 million27.07%Avid Bioservices, Inc., a biologics contract development and manufacturing company, focuses on the development and current Good Manufacturing Practices (cGMP) manufacture of biopharmaceutical products derived f...See Company Profile ...Dividend History.$5.21$3.37$8.44
170.Gritstone Oncology (GRTS)$367.22 million-35.86%Gritstone Oncology Inc. is engaged in the discovery and development of cancer immunotherapies. The company focuses on developing tumor-specific neo-antigens-based therapies for non-small cell lung cancer. Grits...See Company Profile ...Dividend History.$9.91$8.75$32.9
171.AC Immune SA (ACIU)$365.81 million-44.02%AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimers and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinsons, and ...See Company Profile ...Dividend History.$5.29$3.25$12.5
172.Arcus Biosciences (RCUS)$359 million-27.3%Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing cancer immunotherapies in the United States. It is developing various products for treating solid tumors, including AB928, an adenosine receptor antagonist that is in Phase I clinical trial; AB680, a CD73 inhibitor; AB122, an anti-PD-1 antibody that is ...See Company Profile ...Dividend History.$7.83$6.3$14.83
173.Provention Bio (PRVB)$355.4 million471.75%Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disea...See Company Profile ...Dividend History.$10.12$1.52$22.82
174.resTORbio (TORC)$351.29 million14.73%resTORbio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. Its lead program is targeting the...See Company Profile ...Dividend History.$9.89$6.21$16.66
175.XBiotech (XBIT)$345.94 million75.2%XBiotech Inc., incorporated on September 23, 2005, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different ...See Company Profile ...Dividend History.$8.9$2.13$11.74
176.Dynavax (DVAX)$344.85 million-52.57%Dynavax Technologies Corporation (Dynavax), incorporated on November 6, 2000, is a clinical-stage immunotherapy company focused on leveraging the bodys innate and adaptive immune responses through toll-like receptor (TLR) stimulation. The ...See Company Profile ...Dividend History.$4.34$2.6$13.75
177.Replimune Group (REPL)$334.5 million9.83%Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company uses its proprietary Immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version ...See Company Profile ...Dividend History.$10.95$8.88$20.2
178.BioCryst Pharma (BCRX)$331.26 million-60.97%BioCryst Pharmaceuticals, Inc., incorporated on November 15, 1991, is a biotechnology company. The Company designs, optimizes and develops small molecule drugs that block enzymes involved in the pathogenesis of diseases. ...See Company Profile ...Dividend History.$3.15$2.49$9.95
179.Forty Seven (FTSV)$328.56 million-51.21%Forty Seven Inc., a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibo...See Company Profile ...Dividend History.$7.67$6.04$23.83
180.Corbus Pharma (CRBP)$325.68 million-9.25%Corbus Pharmaceuticals Holdings, Inc., incorporated on December 18, 2013, is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat rare, chronic and ...See Company Profile ...Dividend History.$5.3$4.8$9.11
181.Prothena (PRTA)$324.94 million-16.6%Prothena Corporation Public Limited Company, incorporated on September 26, 2012, is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment ...See Company Profile ...Dividend History.$8.59$6.71$14.77
182.Urovant Sciences (UROV)$323.43 million61.76%Urovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for urologic conditions. It is developing vibegron, an oral, once-daily, small molecule beta-3 agonist that is in Phase III trials for the treatment of overactive bladder (OAB) and OAB in men with benign prostatic hyperplasia; and in ...See Company Profile ...Dividend History.$10.66$4.06$14.49
183.Biofrontera AG (BFRA)$322.15 million19.5%Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to ...See Company Profile ...Dividend History.$14.28$11.04$18.32
184.Xeris Pharmaceuticals (XERS)$316.55 million-17.43%Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes ready-to-use injectable and infusible drug formulations. Its proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of highly-concentrated, ready-to-use formulations of peptides, proteins, antibodies, and small molecules using commercially available syringes, auto-injectors, multi-dose pens, and infusion ...See Company Profile ...Dividend History.$10.94$6.85$27.98
185.Rafael (RFL)$313.22 million150.32%Rafael Holdings, Inc. holds commercial real estate assets. The company, through its subsidiaries, engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Rafael Holdings, Inc. is headquartered in Newark, New ...See Company Profile ...Dividend History.$19.85$0$30.86
186.Albireo Pharma (ALBO)$310.89 million3.22%Albireo Pharma, Inc., formerly Biodel Inc., incorporated on December 8, 2003, is a specialty biopharmaceutical company. The Company is focused on the development and commercialization of bile acid modulators to ...See Company Profile ...Dividend History.$25.32$19.1$38.69
187.Scholar Rock Holding (SRRK)$310.46 million-54.46%Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of various medicines for the treatment of serious diseases in which signaling by protein growth factors pl...See Company Profile ...Dividend History.$10.46$9.3$30
188.Clovis Oncology (CLVS)$307.79 million-70.55%Clovis Oncology, Inc., incorporated on April 20, 2009, is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The ...See Company Profile ...Dividend History.$5.29$4.98$35.84
189.KalVista Pharma (KALV)$305.72 million-15.95%KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., incorporated on March 26, 2004, is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule ...See Company Profile ...Dividend History.$16.6$14.5$34.92
190.CASI Pharma (CASI)$298.78 million-15.92%CASI Pharmaceuticals, Inc., incorporated on September 18, 1991, is a biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of therapeutics for cancer and other medical needs. ...See Company Profile ...Dividend History.$3.38$2.73$6.78
191.Rigel Pharma (RIGL)$289.96 million-24.78%Rigel Pharmaceuticals, Inc., incorporated on June 14, 1996, is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted drugs in the therapeutic areas of ...See Company Profile ...Dividend History.$1.73$1.6$3.64
192.Kindred Biosciences (KIN)$288.1 million-36.07%Kindred Biosciences, Inc., incorporated on September 25, 2012, is a development-stage biopharmaceutical company. The Company is focused on developing therapies for pets. The Companys product pipeline consists of small molecules ...See Company Profile ...Dividend History.$7$5.96$15.11
193.ProQR Therapeutics (PRQR)$287.18 million-53.23%ProQR Therapeutics N.V. (ProQR), formerly ProQR Therapeutics B.V., is a pre-clinical stage biopharmaceutical company. The Company is engaged in the discovery and development of Ribonucleic Acid (RNA)-based therapeutics for the ...See Company Profile ...Dividend History.$7.38$6.73$24
194.Assembly Biosciences (ASMB)$285.01 million-52.17%Assembly Biosciences, Inc. operates as a clinical stage biotechnology company. It develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection and novel class of oral sy...See Company Profile ...Dividend History.$10.82$10.58$38.42
195.ADMA Biologics (ADMA)$284.97 million110.88%ADMA Biologics, Inc., incorporated on June 2, 2006, is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious ...See Company Profile ...Dividend History.$5.04$2.08$6.72
196.Unity Biotechnology (UBX)$281.55 million-55.78%Unity Biotechnology, Inc., a preclinical biotechnology company, engages in the research and development of therapeutics to extend human health span. The company's lead drug candidates include UBX0101 for musculoskeletal disease with an initial focus on osteoarthritis; and UBX1967 for ophthalmologic diseases. It is also developing programs in pulmonary disorders. The ...See Company Profile ...Dividend History.$7.19$5.61$24.56
197.Sorrento Therapeutics (SRNE)$281.53 million-9.17%Sorrento Therapeutics, Inc., incorporated on December 4, 2009, is a biopharmaceutical company. The Company is engaged in the discovery, acquisition, development and commercialization of drug therapeutics. Its primary therapeutic focus ...See Company Profile ...Dividend History.$2.18$1.8$6.5
198.Seres Therapeutics (MCRB)$280.98 million-19.03%Seres Therapeutics, Inc., incorporated on October 18, 2010, is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic ...See Company Profile ...Dividend History.$3.66$2.02$9
199.NuCana (NCNA)$277.89 million-31.03%NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. It is developing Acelarin that is in Phase I clinical trials for the treatment of adva...See Company Profile ...Dividend History.$10$4.01$25.82
200.Minerva Neurosciences (NERV)$277.14 million9.79%Minerva Neurosciences, Inc., incorporated on April 23, 2007, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of product candidates to treat ...See Company Profile ...Dividend History.$7.4$4.07$12.95
201.Kadmon (KDMN)$276.32 million20.67%Kadmon Holdings, Inc., incorporated on September 15, 2010, is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of ...See Company Profile ...Dividend History.$2.51$1.63$3.82
202.Eiger BioPharma (EIGR)$270.08 million10.04%Eiger BioPharmaceuticals, Inc., formerly Celladon Corporation, incorporated on February 24, 2012, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of products for the treatment ...See Company Profile ...Dividend History.$11.18$8.4$15.33
203.Geron (GERN)$269.45 million43%Geron Corporation (Geron), incorporated on November 28, 1990, is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, ...See Company Profile ...Dividend History.$1.43$0.95$6.99
204.Verrica Pharmaceuticals (VRCA)$267.32 million28.83%Verrica Pharmaceuticals Inc. develops and commercializes dermatological treatments in the United States. The company is advancing its lead product VP-102, a proprietary topical therapy, in various common skin indications, including Molluscum contagiosum and Verruca Vulgaris. It is also developing 2 Phase 3 trials in molluscum contagiosum under NCT03377803 and NCT03377790. ...See Company Profile ...Dividend History.$10.5$6.44$17.63
205.La Jolla Pharmaceutical (LJPC)$266.37 million8.8%La Jolla Pharmaceutical Company, incorporated on May 8, 2012, is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies to improve outcomes in patients ...See Company Profile ...Dividend History.$10.26$5.01$22.86
206.Recro Pharma (REPH)$264.42 million66.06%Recro Pharma, Inc., incorporated on November 15, 2007, is a clinical-stage specialty pharmaceutical company. The Company is engaged in developing products for hospitals and ambulatory care settings that is developing ...See Company Profile ...Dividend History.$11.79$5.53$12.67
207.PDL BioPharma (PDLI)$262.67 million-20.69%PDL BioPharma, Inc., incorporated on July 24, 1986, seeks to provide return for its shareholders by acquiring and managing a portfolio of companies, products, royalty agreements and debt facilities in ...See Company Profile ...Dividend History.$2.3$2.21$3.89
208.Eloxx Pharmaceuticals (ELOX)$259.97 million-47.38%Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead...See Company Profile ...Dividend History.$6.32$5.14$17.5
209.Evofem Biosciences (EVFM)$250.8 million40.58%Evofem Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes women's sexual and reproductive health products. Its lead product candidate is Amphora that is in Phase 3 trial ...See Company Profile ...Dividend History.$5.3$3.16$7.24
210.Cel-Sci (CVM)$249.88 million164.81%CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and other diseases. The company's lead investigational immunotherapy is Multikine, which is und...See Company Profile ...Dividend History.$7.6$2.37$8.99
211.Compugen (CGEN)$248.3 million77.88%Compugen Ltd., incorporated on February 10, 1993, is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the ...See Company Profile ...Dividend History.$3.86$2$4.31
212.Pfenex (PFNX)$247.58 million188.4%Pfenex Inc., incorporated on November 19, 2009, is a clinical-stage biotechnology company. The Company is engaged in the development of biosimilar and therapeutic equivalent products to branded therapeutics and other ...See Company Profile ...Dividend History.$9.2$3.13$9.2
213.PhaseBio Pharmaceuticals (PHAS)$247.47 million58.49%PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat orphan diseases with an initial focus on cardiopulmonary ...See Company Profile ...Dividend History.$5.04$2.55$16.65
214.Ardelyx (ARDX)$246.41 million213.97%Ardelyx, Inc., incorporated on October 18, 2007, is a clinical-stage biopharmaceutical company. The Companys therapeutics focuses on addressing cardiorenal and gastrointestinal (GI) diseases. The Company operates through the research, development ...See Company Profile ...Dividend History.$5.62$1.6$5.95
215.Xenon Pharma (XENE)$245.12 million50.71%Xenon Pharmaceuticals Inc. (Xenon), incorporated on May 17, 2000, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. ...See Company Profile ...Dividend History.$9.51$5.41$15.15
216.Zynerba Pharma (ZYNE)$245.02 million289.23%Zynerba Pharmaceuticals, Inc., incorporated on January 31, 2007, is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet ...See Company Profile ...Dividend History.$11.56$2.75$16.47
217.Aratana Therapeutics (PETX)$241.09 million-19.74%Aratana Therapeutics, Inc., incorporated on December 1, 2010, is a pet therapeutics company focused on licensing, developing and commercializing of biopharmaceutical products for companion animals. The Companys portfolio includes therapeutic ...See Company Profile ...Dividend History.$4.92$3.3$7.16
218.22nd Century (XXII)$238.05 million-18.88%22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoid...See Company Profile ...Dividend History.$2.02$0$3.29
219.Marker Therapeutics (MRKR)$237.47 million-5.41%Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor in...See Company Profile ...Dividend History.$5.25$3.97$10.6
220.Pieris Pharma (PIRS)$236.1 million79.7%Pieris Pharmaceuticals, Inc., incorporated on May 24, 2013, is a clinical-stage biopharmaceutical company. The Companys pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled ...See Company Profile ...Dividend History.$4.78$2.39$6.04
221.Cellular Biomedicine (CBMG)$234.76 million-29.33%Cellular Biomedicine Group, Inc. (CBMG), incorporated on January 18, 2013, is a biomedicine company. The Company is engaged in the development of treatments for cancerous and degenerative diseases utilizing cell-based ...See Company Profile ...Dividend History.$12.48$10.98$25
222.Avid Bioservices (CDMOP)$229.95 million26.46%Avid Bioservices, Inc., a biologics contract development and manufacturing company, focuses on the development and current Good Manufacturing Practices (cGMP) manufacture of biopharmaceutical products derived f...See Company Profile ...Dividend History.$28.1$20.21$29.5
223.ChromaDex (CDXC)$229.45 million16.33%Chromadex Corporation, incorporated on June 19, 2008, and its subsidiaries ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. provide research and quality-control products and services to the natural products ...See Company Profile ...Dividend History.$3.99$2.79$4.95
224.Aeglea BioTherapeutics (AGLE)$229.11 million8.68%Aeglea BioTherapeutics, Inc., incorporated on December 16, 2013, is a biotechnology company. The Company is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to ...See Company Profile ...Dividend History.$8.14$5.99$10.49
225.Concert Pharma (CNCE)$228.96 million-14.82%Concert Pharmaceuticals, Inc., incorporated on April 12, 2006, is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through ...See Company Profile ...Dividend History.$10.69$9.21$17.83
226.Kamada (KMDA)$227.4 million7.8%Kamada Ltd. develops, produces, and markets specialty plasma-derived protein therapeutics. It operates through two segments, Proprietary Products and Distribution. The company offers respiratory products, inclu...See Company Profile ...Dividend History.$5.39$4.63$6.7
227.Syndax Pharma (SNDX)$226.93 million98.2%Syndax Pharmaceuticals, Inc., incorporated on October 11, 2005, is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The Company?ÇÖs product candidate, ...See Company Profile ...Dividend History.$8.82$3.39$11.11
228.LogicBio Therapeutics (LOGC)$222.06 million6.35%LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is d...See Company Profile ...Dividend History.$11.06$6.34$20.07
229.Inovio Pharma (INO)$219.93 million-45.25%Inovio Pharmaceuticals, Inc. (Inovio), incorporated on June 15, 2001, is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing ...See Company Profile ...Dividend History.$2.19$2.03$6.3
230.Sutro Biopharma (STRO)$216.67 million4.77%Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-f...See Company Profile ...Dividend History.$9.45$7.69$15.9
231.Calithera Biosciences (CALA)$212.96 million1.25%Calithera Biosciences, Inc., incorporated on March 9, 2010, is a clinical-stage pharmaceutical company. The Company focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets ...See Company Profile ...Dividend History.$4.06$3.43$6.9
232.Athersys (ATHX)$208.95 million-1.39%Athersys, Inc., incorporated on June 7, 2005, is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Companys MultiStem cell therapy, an allogeneic stem ...See Company Profile ...Dividend History.$1.42$1.2$2.23
233.Five Prime Therapeutics (FPRX)$207.28 million-38.06%Five Prime Therapeutics, Inc., incorporated on December 20, 2001, is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. The Company has three product candidates in clinical development ...See Company Profile ...Dividend History.$5.76$4.89$16
234.Spero Therapeutics (SPRO)$206.46 million80.49%Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections in the United S...See Company Profile ...Dividend History.$11.1$5.52$14.48
235.MannKind (MNKD)$203.49 million13.21%MannKind Corporation (MannKind), incorporated on February 14, 1991, is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. The ...See Company Profile ...Dividend History.$1.2$0.94$2.34
236.Chiasma (CHMA)$201.44 million55.31%Chiasma, Inc., incorporated on April 12, 2001, is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using ...See Company Profile ...Dividend History.$4.83$2.11$9.25
237.Ocular Therapeutix (OCUL)$199.24 million8.29%Ocular Therapeutix, Inc., incorporated on September 12, 2006, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies for diseases and conditions of the eye ...See Company Profile ...Dividend History.$4.31$2.35$7.31
238.Redhill Biopharma (RDHL)$198.56 million41.44%RedHill Biopharma Ltd., incorporated on August 3, 2009, is a biopharmaceutical company. The Company is focused on the development and commercialization of clinical-stage, orally-administered, small molecule drugs for the treatment ...See Company Profile ...Dividend History.$7.85$5.13$9.57
239.Molecular Templates (MTEM)$194.33 million35.15%Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other diseases. The company primarily dev...See Company Profile ...Dividend History.$5.46$3.19$8.77
240.Evelo Biosciences (EVLO)$194.14 million-49.65%Evelo Biosciences, Inc., a biotechnology company, focuses on the development of monocolonal microbials for the treatment of inflammatory diseases and cancer. It is involved in developing EDP1066 and EDP1815, wh...See Company Profile ...Dividend History.$6.53$4.9$15.89
241.Constellation Pharmaceuticals (CNST)$191.5 million89.28%Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapeutics that address serious unmet medical needs in patients with cancers associated w...See Company Profile ...Dividend History.$7.59$4.01$14.04
242.Enochian Biosciences (ENOB)$187.78 million-26.34%Enochian Biosciences Inc., a biopharmaceutical company, identifies, develops, manufactures, and commercializes gene therapies for HIV AIDS and cancer patients. Its lead candidate include ENO-1001 a genetic...See Company Profile ...Dividend History.$4.81$4.05$9.5
243.Cue Biopharma (CUE)$186.31 million75.74%Cue Biopharma, Inc., a biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers and autoimmune disorders. The company's lead drug ca...See Company Profile ...Dividend History.$8.26$4.16$9.94
244.Foamix Pharma (FOMX)$183.8 million-4.46%Foamix Pharmaceuticals Ltd., incorporated on January 19, 2003, is a clinical-stage pharmaceutical company. The Company is engaged in the development and commercialization of foam-based formulations, using its technology, which includes ...See Company Profile ...Dividend History.$3.43$1.97$7.6
245.Adaptimmune Therapeutics (ADAP)$183.27 million-70.43%Adaptimmune Therapeutics plc, incorporated on December 03, 2014, is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) ...See Company Profile ...Dividend History.$1.7$1.37$14.54
246.CorMedix (CRMD)$182.09 million539.53%CorMedix Inc., incorporated on July 28, 2006, is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment ...See Company Profile ...Dividend History.$8.25$0$13.7
247.Affimed (AFMD)$177.86 million-6.43%Affimed N.V., incorporated on May 1, 2014, is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Companys product candidates are developed in the field of immuno-oncology, ...See Company Profile ...Dividend History.$2.91$2.52$5.3
248.Sol-Gel Technologies (SLGL)$175.43 million40.2%Sol-Gel Technologies Ltd., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery ...See Company Profile ...Dividend History.$8.44$5.41$11.36
249.Acorda Therapeutics (ACOR)$174.81 million-79.78%Acorda Therapeutics, Inc., incorporated on March 17, 1995, is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. ...See Company Profile ...Dividend History.$3.15$2.27$21.63
250.Cerecor (CERC)$163.96 million0.31%Cerecor, Inc., incorporated on January 31, 2011, is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company ...See Company Profile ...Dividend History.$3.24$2.71$7.65
251.EyePoint Pharmaceuticals (EYPT)$162.59 million-17.99%EyePoint Pharmaceuticals, Inc., a specialty biopharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases. The company's lead product is ILUVIEN for the treatment ...See Company Profile ...Dividend History.$1.55$1.19$3.94
252.Mustang Bio (MBIO)$161.74 million39.8%Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel cancer immunotherapy products based on the chimeric antigen receptor engine...See Company Profile ...Dividend History.$4.11$2.18$10.2
253.Osmotica Pharmaceuticals (OSMT)$160.71 million-61.29%Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, develops, manufactures, and commercializes specialty products that target markets with underserved patient populations. The company's promo...See Company Profile ...Dividend History.$3$2.2$9.9
254.Taiwan Liposome (TLC)$160.63 million-3.9%Taiwan Liposome Company, Ltd., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of nanomedicines that combine its proprietary lipid-assembled drug delivery pla...See Company Profile ...Dividend History.$5.17$4.88$11
255.XOMA (XOMA)$159.11 million44.11%XOMA Corporation, incorporated on December 31, 2011, is a development-stage biotechnology company with a portfolio of therapeutic antibodies. The Company focuses on the discovery and development of monoclonal antibody-based therapeutics. ...See Company Profile ...Dividend History.$18.23$11.02$20.29
256.Nabriva Therapeutics AG (NBRV)$158.98 million51.37%Nabriva Therapeutics AG is an Austria-based clinical-stage biopharmaceutical company engaged in the research and development of antibiotics to treat infections. Its lead product candidate, lefamulin, is a pleuromutilin antibiotic for ...See Company Profile ...Dividend History.$2.21$1.12$3.27
257.Acasti Pharma (ACST)$157.25 million155.42%Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. The Company is involved ...See Company Profile ...Dividend History.$2.12$0.52$2.95
258.Tyme Technologies (TYME)$152.25 million-63.04%Tyme Technologies, Inc., a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New ...See Company Profile ...Dividend History.$1.36$0.92$4.64
259.GlycoMimetics (GLYC)$152.1 million-61.14%GlycoMimetics, Inc., incorporated on April 4, 2003, is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs. The Company operates through the identification and ...See Company Profile ...Dividend History.$3.68$2.64$15.03
260.BioXcel Therapeutics (BTAI)$150.03 million135.49%BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. Th...See Company Profile ...Dividend History.$9.09$2.41$12
261.AmpliPhi Biosciences (APHB)$148.96 million2019.33%AmpliPhi Biosciences Corporation, incorporated on March 9, 1989, is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in ...See Company Profile ...Dividend History.$4.45$0.15$3.7
262.Strongbridge Biopharma (SBBP)$147.76 million-37.72%Strongbridge Biopharma plc, incorporated on May 26, 2015, is a global commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies for a range of diseases. ...See Company Profile ...Dividend History.$2.79$2.07$6.52
263.Anavex Life Sciences (AVXL)$146.84 million80.13%Anavex Life Sciences Corp., incorporated on January 23, 2004, is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and ...See Company Profile ...Dividend History.$2.81$1.25$4.09
264.IMV (IMV)$145.36 million-43.86%IMV Inc., a clinical-stage immuno-oncology company, together with its subsidiaries, develops products based on its platform and products with a primary focus on T cell activating therapies for cancer. The compa...See Company Profile ...Dividend History.$2.88$2.25$7.07
265.Lexicon Pharma (LXRX)$144.34 million-78.61%Lexicon Pharmaceuticals, Inc., incorporated on July 7, 1995, is a biopharmaceutical company. The Company focuses on the development and commercialization of breakthrough treatments for human disease. The Companys drug programs ...See Company Profile ...Dividend History.$1.42$1.13$11.51
266.Paratek Pharma (PRTK)$143.89 million-10.33%Paratek Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics based upon tetracycline chemistry in the United States. Its lead produ...See Company Profile ...Dividend History.$4.6$2.87$12.2
267.Celyad SA (CYAD)$143.67 million-26.87%Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat ...See Company Profile ...Dividend History.$13.28$10.19$28.89
268.Arcturus Therapeutics (ARCT)$142.75 million127.37%Arcturus Therapeutics Ltd., an RNA medicines company, develops nucleic acid medicines to treat diseases with unmet medical needs. Its RNA therapeutics platforms could be applied in various types of RNA medicine...See Company Profile ...Dividend History.$10.3$4.11$15.5
269.Novavax (NVAX)$141.26 million195.65%Novavax, Inc. (Novavax), incorporated on June 18, 1987, is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through ...See Company Profile ...Dividend History.$5.44$4.01$51.6
270.Kala Pharmaceuticals (KALA)$137.67 million-19.43%Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for t...See Company Profile ...Dividend History.$3.94$3.5$11.4
271.BioTime (BTX)$137.66 million1.09%BioTime, Inc., incorporated on November 30, 1990, is a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases. The Companys clinical programs are based on two platform ...See Company Profile ...Dividend History.$0.92$0.66$2.63
272.Aptose Biosciences (APTO)$137.39 million27.75%Aptose Biosciences Inc. (Aptose), incorporated on November 1, 2006, is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and ...See Company Profile ...Dividend History.$2.44$1.57$3.13
273.NantKwest (NK)$135.13 million11.21%NantKwest, Inc., a clinical-stage immunotherapy biotechnology company, develops immunotherapeutic treatments for cancer, infectious diseases, and inflammatory diseases in the United States. The compan...See Company Profile ...Dividend History.$1.29$0.93$4.23
274.Jounce Therapeutics (JNCE)$134.18 million13.35%Jounce Therapeutics, Inc., a clinical stage immunotherapy company, develops therapies for the treatment of cancer. Its lead product candidate is JTX-2011, a clinical stage monoclonal antibody that binds to and ...See Company Profile ...Dividend History.$3.82$2.66$7.35
275.scPharmaceuticals (SCPH)$129.4 million95.48%scPharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix, a drug-dev...See Company Profile ...Dividend History.$7.35$2.44$7.65
276.Chimerix (CMRX)$126.21 million-19.46%Chimerix, Inc., incorporated on April 7, 2000, is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. Its lead compound, brincidofovir, ...See Company Profile ...Dividend History.$2.07$1.74$4.4
277.Menlo Therapeutics (MNLO)$123.28 million21.12%Menlo Therapeutics Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of serlopitant for the treatment of pruritus associated with dermatologic conditions in the Unit...See Company Profile ...Dividend History.$4.99$2.69$12
278.Fortress Biotech (FBIO)$122.42 million123.26%Fortress Biotech, Inc., formerly Coronado Biosciences, Inc., incorporated on June 28, 2006, is a biopharmaceutical company. The Company is involved in the development of immunotherapy agents for the treatment of ...See Company Profile ...Dividend History.$1.92$0.49$2.59
279.Mersana Therapeutics (MRSN)$122.09 million-46.57%Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company focusing on the development of oncology therapeutics in the United States and Canada. The company develops Dolaflexin, an antibody drug con...See Company Profile ...Dividend History.$2.18$2.03$15.93
280.Aldeyra Therapeutics (ALDX)$120.88 million-40.96%Aldeyra Therapeutics, Inc., formerly Aldexa Therapeutics, Inc., incorporated on August 13, 2004, is a biotechnology company. The Companys principal activities include raising capital and research and development activities. The Companys ...See Company Profile ...Dividend History.$4.9$4.31$16.7
281.Nymox Pharmaceutical (NYMX)$120.11 million37.02%Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of ...See Company Profile ...Dividend History.$1.8$1.25$2.93
282.Checkpoint Therapeutics (CKPT)$119.37 million48.9%Checkpoint Therapeutics, Inc., an immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company...See Company Profile ...Dividend History.$2.71$1.5$5.2
283.Galmed Pharma (GLMD)$116.24 million-28.55%Galmed Pharmaceuticals Ltd., incorporated on July 31, 2013, is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver ...See Company Profile ...Dividend History.$4.88$4.4$14.65
284.Windtree Therapeutics (WINT)$115.88 million-16.47%Windtree Therapeutics, Inc., formerly Discovery Laboratories, Inc., incorporated on November 6, 1992, is a biotechnology company. The Company is focused on developing KL4 surfactant therapies for respiratory diseases and other ...See Company Profile ...Dividend History.$3.6$2.05$5.35
285.AVEO Pharma (AVEO)$115.43 million-55.84%AVEO Pharmaceuticals, Inc. (AVEO), incorporated on October 19, 2001, is a biopharmaceutical company. The Companys platform delivers insights into cancer and related disease. The Companys product candidates include Tivozanib, Ficlatuzumab, ...See Company Profile ...Dividend History.$0.71$0.49$3.59
286.Sunesis Pharma (SNSS)$114.1 million150%Sunesis Pharmaceuticals, Inc., incorporated on February 10, 1998, is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of ...See Company Profile ...Dividend History.$1.03$0.2$2.26
287.Aptinyx (APTX)$113.16 million-77.99%Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous...See Company Profile ...Dividend History.$3.64$2.88$32.25
288.Fortress Biotech (FBIOP)$110.04 million35.85%Fortress Biotech, Inc. develops and commercializes pharmaceutical and biotechnology products. The company develops CNDO-109, a lysate that treats cancer-related and other conditions; tramadol HCl for managing p...See Company Profile ...Dividend History.$20.5$11.9$21.95
289.Matinas BioPharma (MTNB)$108.8 million13.7%Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines ...See Company Profile ...Dividend History.$0.68$0.4$1.5
290.Sesen Bio (SESN)$108.36 million-24.65%Sesen Bio, Inc., a late-stage clinical company, develops next-generation antibody-drug conjugate therapies for patients with cancer. It develops its products based on its Targeted Protein Therapeutics (TPTs) pl...See Company Profile ...Dividend History.$1.07$0.66$2.6
291.Eton Pharmaceuticals (ETON)$107.79 million-6.7%Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical product using the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. It pr...See Company Profile ...Dividend History.$5.71$5.13$10.2
292.Corvus Pharma (CRVS)$105.68 million5.45%Corvus Pharmaceuticals, Inc., incorporated on January 27, 2014, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapies. The Company is developing drugs ...See Company Profile ...Dividend History.$3.87$3.2$10.93
293.ERYTECH Pharma (ERYP)$101.97 million-18.44%ERYTECH Pharma S.A., a biopharmaceutical company, develops therapies for severe forms of cancer and orphan diseases. It is developing a pipeline of product candidates targeting solid and liquid tumors for patie...See Company Profile ...Dividend History.$5.22$5.2$10.71
294.Gamida Cell (GMDA)$101.82 million-58.84%Gamida Cell Ltd., a clinical stage biopharmaceutical company, focuses on developing cell therapies to cure cancer, and rare and serious hematologic diseases in the United States, the European Union, and interna...See Company Profile ...Dividend History.$4.03$2.93$15.41
295.AgeX Therapeutics (AGE)$101.57 million-13.71%AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of therapeutics for age-related degenerative diseases in the United Stated. The company is developing AGEX-BAT1...See Company Profile ...Dividend History.$2.58$1.13$5.95
296.Allena Pharmaceuticals (ALNA)$101.21 million-22.57%Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and ...See Company Profile ...Dividend History.$4.22$3.62$12
297.PolarityTE (PTE)$101.02 million-70.51%PolarityTE, Inc., a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, bi...See Company Profile ...Dividend History.$4.07$3.4$23.06
298.Aridis Pharmaceuticals (ARDS)$99.38 million-2.07%Aridis Pharmaceuticals Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening in...See Company Profile ...Dividend History.$10.86$6.92$13.38
299.Aduro Biotech (ADRO)$99.37 million-53.03%Aduro Biotech, Inc., incorporated on May 5, 2011, is an immunotherapy company. The Company focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, ...See Company Profile ...Dividend History.$1.24$1.15$7.64
300.OncoCyte (OCX)$99.16 million15.22%OncoCyte Corporation (OncoCyte), incorporated on September 30, 2009, is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery ...See Company Profile ...Dividend History.$1.59$0$6.92
301.Savara (SVRA)$97.23 million-68.82%Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for th...See Company Profile ...Dividend History.$2.36$2.11$11.96
302.Tiziana Life Sciences (TLSA)$94.64 million0.66%Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of therapeutics to treat diseases in oncology and immunology in the United Kingdom. The company's prod...See Company Profile ...Dividend History.$7.66$5$12.17
303.Synlogic (SYBX)$94.12 million-64.19%Synlogic, Inc. a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its ...See Company Profile ...Dividend History.$2.51$2.32$14.59
304.Verastem (VSTM)$93.04 million-63.54%Verastem, Inc., incorporated on August 4, 2010, is a biopharmaceutical company. The Company is focused on discovering and developing drugs to improve outcomes for patients with cancer. The Company operates ...See Company Profile ...Dividend History.$1.23$1.16$9.32
305.Aquestive Therapeutics (AQST)$90.01 million-46.67%Aquestive Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs. Its products are developed using its Ph...See Company Profile ...Dividend History.$3.36$2.96$20.7
306.MediWound (MDWD)$89.27 million-21.92%MediWound Ltd., incorporated on January 27, 2000, is a biopharmaceutical company. The Company focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic and other ...See Company Profile ...Dividend History.$3.17$2.55$6.75
307.Avadel Pharma (AVDL)$88.02 million-14.73%Avadel Pharmaceuticals, PLC is a specialty pharmaceutical company. The Company offers various drug delivery platforms, including Micropump, LiquiTime, Trigger Lock and Medusa. Micropump is a microparticulate system that allows the ...See Company Profile ...Dividend History.$2.2$1.03$5.12
308.Millendo Therapeutics (MLND)$86.73 million-35.97%Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of various treatments for orphan endocrine diseases in the United States. The company's lead drug candidates i...See Company Profile ...Dividend History.$5.09$4.56$17.34
309.Vaccinex (VCNX)$86.2 million59.34%Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is VX15 that is in Phase Ib 002FII clinical trials for ...See Company Profile ...Dividend History.$5.8$3.32$10.18
310.Fennec Pharmaceuticals (FENC)$84.57 million-26.33%Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has com...See Company Profile ...Dividend History.$4.7$3.26$8.74
311.Tocagen (TOCA)$84.3 million-58.22%Tocagen Inc., a clinical-stage cancer-selective gene therapy company, focuses on developing and commercializing product candidates designed to activate a patient's immune system against their cancer. Its cancer...See Company Profile ...Dividend History.$3.43$2.91$15.8
312.Brainstorm Cell Therapeutics (BCLI)$83.45 million13.21%Brainstorm Cell Therapeutics Inc., incorporated on November 15, 2006, is a biotechnology company. The Company is engaged in developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic ...See Company Profile ...Dividend History.$4.02$2.92$4.5
313.Trevena (TRVN)$83.34 million129.79%Trevena Inc., incorporated on November 9, 2007, is a biopharmaceutical company, which is engaged in developing various therapies. The Company is developing OLINVO, a u-receptor G protein pathway selective modulator ...See Company Profile ...Dividend History.$0.99$0.38$3.58
314.Iterum Therapeutics (ITRM)$82.14 million26.55%Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. The company is developing sulopenem, ...See Company Profile ...Dividend History.$6.34$4.7$9.4
315.Merrimack Pharma (MACK)$81.75 million41.19%Merrimack Pharmaceuticals, Inc., incorporated on July 6, 2010, is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing medicines consisting of therapeutics paired with companion diagnostics for ...See Company Profile ...Dividend History.$5.45$2.63$5.95
316.Arbutus Biopharma (ABUS)$80.68 million-59.01%Arbutus Biopharma Corporation, formerly Tekmira Pharmaceuticals Corporation, is a therapeutic solutions company. The Company is engaged in discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B ...See Company Profile ...Dividend History.$1.57$1.29$10.85
317.Selecta Biosciences (SELB)$80.07 million-30.45%Selecta Biosciences, Inc., incorporated on December 10, 2007, is a clinical-stage biopharmaceutical company. The Company using its synthetic vaccine particle (SVP) technology to discover and develop targeted therapies that are ...See Company Profile ...Dividend History.$1.85$1.41$16.55
318.Genocea Biosciences (GNCA)$79.45 million1034.48%Genocea Biosciences, Inc., incorporated on August 16, 2006, is harnessing the power of T cell immunity to develop vaccines and immunotherapies. The Company uses its discovery platform, AnTigen Lead Acquisition ...See Company Profile ...Dividend History.$3.29$2.24$11.28
319.Catalyst Biosciences (CBIO)$77.65 million-20.66%CB 813dThe Companys product candidate, CB 813d, is a next-generation Factor VIIa that has completed Phase I clinical trial. The clinical trial has evaluated the safety and tolerability, pharmacokinetics, pharmacodynamics ...See Company Profile ...Dividend History.$6.26$6.01$11.44
320.Abeona Therapeutics (ABEO)$76.71 million-57.84%Abeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., incorporated on June 22, 1989, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Companys lead ...See Company Profile ...Dividend History.$3.01$1.46$14.7
321.Idera Pharma (IDRA)$76.29 million13.36%Idera Pharmaceuticals, Inc., incorporated on August 24, 2005, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for oncology and rare diseases. The Company utilizes ...See Company Profile ...Dividend History.$3.14$2.08$10.3
322.Neon Therapeutics (NTGN)$74.28 million-35.59%Neon Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in developing neoantigen-targeted therapies for cancers in the United States. It is developing NEO-PV-01, a neoantigen vaccine that is ...See Company Profile ...Dividend History.$3.24$2.23$12.69
323.Liquidia Technologies (LQDA)$73.78 million-82.08%Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder fo...See Company Profile ...Dividend History.$3.86$3.25$38.46
324.InflaRx (IFRX)$73.74 million-91.94%InflaRx N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology primarily in the United States and Europe. Its C5a is an inflammatory mediator inv...See Company Profile ...Dividend History.$2.93$2.45$53.1
325.Alpine Immune Sciences (ALPN)$73.01 million25.27%Alpine Immune Sciences, Inc. focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders, and other diseases. Its lead programs include ALPN-101...See Company Profile ...Dividend History.$4.61$3.41$8.24
326.Catabasis Pharma (CATB)$72.87 million39.59%Catabasis Pharmaceuticals, Inc., incorporated on June 26, 2008, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics based on its Safely Metabolized ...See Company Profile ...Dividend History.$6.1$3.6$9.76
327.vTv Therapeutics (VTVT)$72.65 million-48.68%vTv Therapeutics Inc., incorporated on April 02, 2015, is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of orally administered small molecule drug candidates. The ...See Company Profile ...Dividend History.$1.36$0.68$6.09
328.Orgenesis (ORGS)$72.14 million-4.93%Orgenesis Inc., a service and research company, focus on the development and manufacture of cell therapy for advanced medicinal products in the field of regenerative medicine industry. It operates through two s...See Company Profile ...Dividend History.$4.44$3.78$9.25
329.Ampio Pharma (AMPE)$70.82 million30.35%Ampio Pharmaceuticals, Inc., incorporated on March 24, 2010, is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there ...See Company Profile ...Dividend History.$0.52$0.36$1.31
330.Otonomy (OTIC)$69.17 million15.68%Otonomy, Inc., incorporated on May 6, 2008, is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. The Companys ...See Company Profile ...Dividend History.$2.14$1.5$3.16
331.Infinity Pharma (INFI)$68.46 million-0.85%Infinity Pharmaceuticals, Inc., incorporated on May 11, 2000, is a biopharmaceutical company. The Company is engaged in the discovery, development and delivery of medicines to treat diseases. The Company develops ...See Company Profile ...Dividend History.$1.17$1$2.92
332.Aravive (ARAV)$67.73 million63.07%Aravive, Inc., a clinical stage biotechnology company, focuses on developing therapies for solid tumors and hematologic malignancies. It is developing AVB-S6-500, a GAS6 binding protein and AXL decoy receptor, ...See Company Profile ...Dividend History.$5.74$3.07$9.78
333.Ovid Therapeutics (OVID)$67.54 million32.92%Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate wh...See Company Profile ...Dividend History.$2.14$1.53$6.82
334.Eyenovia (EYEN)$67.13 million46.32%Eyenovia, Inc., a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. It is developing MicroProst, which is in Phase III clinical trials fo...See Company Profile ...Dividend History.$4.17$2.4$6.98
335.Cocrystal Pharma (COCP)$65.57 million-52.22%Cocrystal Pharma, Inc., a clinical stage biotechnology company, engages in discovering and developing various novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza v...See Company Profile ...Dividend History.$1.72$1.51$5.28
336.Kezar Life Sciences (KZR)$64.69 million-85.68%Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the United States. I...See Company Profile ...Dividend History.$3.38$2.82$36.33
337.Spring Bank Pharma (SBPH)$64.03 million-62.56%Spring Bank Pharmaceuticals, Inc., incorporated on May 12, 2008, is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of a class of therapeutics using its ...See Company Profile ...Dividend History.$3.89$3.53$15
338.Curis (CRIS)$63.75 million172.46%Curis, Inc., incorporated on February 14, 2000, is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Companys drug candidate is CUDC-907, an ...See Company Profile ...Dividend History.$1.88$0.6$2.9
339.Pluristem Therapeutics (PSTI)$62.93 million420.25%Pluristem Therapeutics Inc., incorporated on May 10, 2001, is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Companys lead ...See Company Profile ...Dividend History.$4.11$0.4$5.93
340.Equillium (EQ)$62.66 million-54.78%Equillium, Inc., a biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is EQ001, a clinical-stage mo...See Company Profile ...Dividend History.$3.69$3.1$19.69
341.Champions Oncology (CSBR)$61.82 million-23.18%Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an ap...See Company Profile ...Dividend History.$6$5.2$17.9
342.AquaBounty (AQB)$61.79 million39.51%AquaBounty Technologies, Inc., incorporated on December 17, 1991, is a biotechnology company engaged in research, development and commercialization of the commercial viability of a group of proteins, antifreeze proteins (AFPs). ...See Company Profile ...Dividend History.$2.86$1.51$5.45
343.NewLink Genetics (NLNK)$61.19 million8.55%NewLink Genetics Corporation (NewLink), incorporated on June 4, 1999, is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Companys portfolio ...See Company Profile ...Dividend History.$1.65$1.28$2.85
344.Marinus Pharma (MRNS)$60.82 million-39.37%Marinus Pharmaceuticals, Inc., incorporated on August 14, 2003, is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product ...See Company Profile ...Dividend History.$1.74$0.77$10.54
345.Opiant Pharmaceuticals (OPNT)$58.51 million-6.92%Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops pharmacological treatments for substance use, addictive and eating disorders. The company offers NARCAN nasal spray, a treatment to rev...See Company Profile ...Dividend History.$13.45$9.98$24
346.VBI Vaccines (VBIV)$58.27 million-64.81%VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines ...See Company Profile ...Dividend History.$0.56$0.54$2.78
347.Applied Genetic (AGTC)$58.03 million52.61%Applied Genetic Technologies Corporation, incorporated on October 24, 2003, is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases ...See Company Profile ...Dividend History.$3.8$2.26$7.5
348.Novan (NOVN)$57.55 million224.1%Novan, Inc. is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its ...See Company Profile ...Dividend History.$2.69$0.65$3.24
349.CohBar (CWBR)$57.04 million-56.59%CohBar, Inc., a clinical stage biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs for the treatment of age-related diseases. The...See Company Profile ...Dividend History.$1.35$1.24$4.92
350.Bellicum Pharma (BLCM)$56.79 million-56.51%Bellicum Pharmaceuticals, Inc., incorporated on July 14, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing cellular immunotherapies for various forms of cancer, including hematological ...See Company Profile ...Dividend History.$1.27$0.78$6.64
351.Unum Therapeutics (UMRX)$56.72 million-57.95%Unum Therapeutics Inc., a clinical stage biopharmaceutical company, develops and commercializes immunotherapy products designed to harness the power of a patient's immune system to cure cancer. Its lead product candidate is the ACTR087 used in combination with rituximab, which is in Phase I clinical trials to treat adult patients with ...See Company Profile ...Dividend History.$1.85$1.5$12.98
352.Verona Pharma (VRNA)$56.05 million-56.17%Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and IIa clinical trials that acts as a bronchodilator and an anti-inflammatory ...See Company Profile ...Dividend History.$4.3$3.65$14.5
353.Oramed Pharma (ORMP)$55.4 million-4.33%Oramed Pharmaceuticals Inc. (Oramed) is engaged in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. OramedÆs flagship product, an orally ingestible insulin capsule in ...See Company Profile ...Dividend History.$2.87$2.78$5.05
354.Surface Oncology (SURF)$51.54 million-56.37%Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies. The company's lead product candidate is the SRF231 that is in Phase I clinical trial targeting p...See Company Profile ...Dividend History.$1.85$1.85$12.65
355.Moleculin Biotech (MBRX)$51.07 million7.69%Moleculin Biotech, Inc., incorporated on July 28, 2015, is a preclinical and clinical-stage pharmaceutical company. The Company is focused on the development of anti-cancer drug candidates. The Companys lead drug ...See Company Profile ...Dividend History.$1.12$0.78$3.15
356.PLx Pharma (PLXP)$50.41 million245.75%PLx Pharma Inc., a late-stage specialty pharmaceutical company, focuses on developing non-steroidal anti-inflammatory drugs (NSAIDs) and other analgesics. The company's lead product candidates are Aspertec 81 m...See Company Profile ...Dividend History.$5.29$1$7.41
357.Immutep (IMMP)$49.61 million-16.09%Immutep Limited, a biotechnology company, engages in the research, development, and commercialization of biological products. The company develops immunotherapeutic products for the treatment of cancer and auto...See Company Profile ...Dividend History.$1.46$1.27$4.21
358.ASLAN Pharmaceuticals (ASLN)$49.01 million-56.02%ASLAN Pharmaceuticals Limited, a clinical-stage oncology-focused biopharmaceutical company, engages in the development of drugs for prevalent cancers. It targets diseases that are prevalent in Asia, and orphan ...See Company Profile ...Dividend History.$1.57$1.5$8.14
359.Forward Pharma AS (FWP)$47.56 million16.36%Forward Pharma Au002FS operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory ...See Company Profile ...Dividend History.$0.91$0.71$3.3
360.Cidara Therapeutics (CDTX)$43.32 million-10.64%Cidara Therapeutics, Inc., formerly K2 Therapeutics, Inc., incorporated on December 06, 2012, is a clinical-stage biotechnology company. The Company is engaged in the discovery, development and commercialization of anti-infectives. The ...See Company Profile ...Dividend History.$2.1$1.22$4.95
361.Aclaris Therapeutics (ACRS)$43.02 million-85.93%Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a clinical-stage specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological ...See Company Profile ...Dividend History.$1.04$0.74$16.07
362.Outlook Therapeutics (OTLK)$42.91 million210.42%Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibody for various ophthalmic indications. Its lead product candidate is ONS-5...See Company Profile ...Dividend History.$1.49$0.85$10.96
363.VIVUS (VVUS)$42.68 million79.82%VIVUS, Inc., incorporated on May 16, 1996, is a biopharmaceutical company. The Company operates in the development and commercialization of therapeutic products segment. It provides over two therapies approved by ...See Company Profile ...Dividend History.$4.01$2.15$6.41
364.Akari Therapeutics (AKTX)$42.67 million21.66%Akari Therapeutics, Plc, formerly Celsus Therapeutics Plc, incorporated on October 7, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of treatments for a ...See Company Profile ...Dividend History.$1.91$1.56$9.2
365.Vascular Biogenics (VBLT)$41.98 million20.62%Vascular Biogenics Ltd., incorporated on January 31, 2000, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for cancer. The Companys program ...See Company Profile ...Dividend History.$1.17$0.6$1.9
366.Proteostasis Therapeutics (PTI)$41.84 million-74.72%Proteostasis Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in discovery and development of therapeutics that treat diseases caused by an imbalance in the proteostasis network, a set ...See Company Profile ...Dividend History.$0.82$0.61$10.38
367.CTI BioPharma (CTIC)$41.7 million1.51%CTI BioPharma Corp. (CTI), incorporated on September 4, 1991, is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers. The ...See Company Profile ...Dividend History.$0.74$0.6$2.3
368.BiondVax Pharma (BVXV)$40.92 million22.43%BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company. The Company holds a worldwide exclusive license granted by Yeda Research and Development Ltd., the commercial arm of the Weizmann Institute, Israel, ...See Company Profile ...Dividend History.$5.84$3.51$7.26
369.Evogene (EVGN)$40.75 million-14.65%Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits ...See Company Profile ...Dividend History.$1.69$1.34$3.32
370.IntelGenx Technologies (IGXT)$39.85 million-39.96%IntelGenx Technologies Corp., a drug delivery company, focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers RIZAPORT, an oral thin ...See Company Profile ...Dividend History.$0.43$0.39$1.83
371.ImmuCell (ICCC)$39.31 million-26.24%ImmuCell Corporation, incorporated on February 9, 1987, is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity ...See Company Profile ...Dividend History.$5.2$5.15$9.3
372.VistaGen Therapeutics (VTGN)$39.21 million-38.67%VistaGen Therapeutics, Inc., incorporated on October 6, 2005, is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing product candidates for patients with diseases and disorders involving ...See Company Profile ...Dividend History.$0.92$0.38$2.44
373.Celsion (CLSN)$38.7 million25.53%Celsion Corporation (Celsion), incorporated on May 17, 2000, is an oncology drug development company. The Company is focused on developing a portfolio of cancer treatments, including directed chemotherapies, deoxyribonucleic acid ...See Company Profile ...Dividend History.$1.77$1.35$2.95
374.Bellerophon Therapeutics (BLPH)$37.98 million-36.35%Bellerophon Therapeutics, Inc., incorporated on October 17, 2013, is a clinical-stage therapeutics company. The Company is focused on developing products at the intersection of drugs and devices that address medical ...See Company Profile ...Dividend History.$0.51$0.49$1.33
375.Leap Therapeutics (LPTX)$37.88 million-16%Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-relate...See Company Profile ...Dividend History.$1.68$1.35$8.17
376.Actinium Pharma (ATNM)$37.56 million-44.03%Actinium Pharmaceuticals, Inc. (Actinium), incorporated on March 20, 2013, is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its ...See Company Profile ...Dividend History.$0.22$0.19$0.87
377.Zosano Pharma (ZSAN)$36.15 million-4.25%Zosano Pharma Corporation, incorporated on January 26, 2012, is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs ...See Company Profile ...Dividend History.$2.03$1.85$6.65
378.AEterna Zentaris (AEZS)$36.06 million-39.8%Aeterna Zentaris Inc., incorporated on October 12, 1990, is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and womens health. The Company operates through the ...See Company Profile ...Dividend History.$1.77$1.29$5.57
379.Melinta Therapeutics (MLNT)$34.74 million-35.35%Melinta Therapeutics, Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes various anti-infectives for the treatment of bacterial infectious diseases in North America. It off...See Company Profile ...Dividend History.$2.56$1.62$24.9
380.Altimmune (ALT)$34.13 million3.4%Altimmune, Inc., a clinical stage immunotherapeutic biotechnology company, focuses on discovering and developing immunotherapies and vaccines to address the unmet medical needs. The company develops NasoVAX, an...See Company Profile ...Dividend History.$2.13$1.7$36.25
381.DiaMedica Therapeutics (DMAC)$33.77 million-7.56%DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for neurological and kidney diseases. The company's lead product is DM199, a recombinant human t...See Company Profile ...Dividend History.$2.69$2.15$10
382.BioLineRx (BLRX)$32.37 million575%BioLine RX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates ...See Company Profile ...Dividend History.$2.97$2.32$27.6
383.Innovate Biopharmaceuticals (INNT)$32.1 million-60.61%Innovate Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company's lead product candidate is INN-202 that has completed Pha...See Company Profile ...Dividend History.$0.91$0.73$8.78
384.Protalix BioTherapeutics (PLX)$31.16 million-32.26%Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the ...See Company Profile ...Dividend History.$0.21$0$0.83
385.Celldex Therapeutics (CLDX)$31.1 million-44.41%Celldex Therapeutics, Inc., incorporated on December 9, 1983, is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer ...See Company Profile ...Dividend History.$2.09$2.01$11.55
386.SELLAS Life Sciences (SLS)$30.95 million-88.89%SELLAS Life Sciences Group, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications. The company's lead product candidate is g...See Company Profile ...Dividend History.$0.14$0.1$2.46
387.Sierra Oncology (SRRA)$30.79 million-68.77%Sierra Oncology, Inc., formerly ProNAi Therapeutics, Inc., incorporated on May 8, 2003, is a clinical-stage drug development company. The Company?ÇÖs lead drug candidate, SRA737, is orally bioavailable small molecule inhibitor ...See Company Profile ...Dividend History.$0.41$0.4$2.01
388.Aptevo Therapeutics (APVO)$30.4 million-48.67%Aptevo Therapeutics Inc., incorporated on February 22, 2016, is a biotechnology company. The Company is focused on oncology and hematology therapeutics. The Company is engaged in the discovery, development, commercialization ...See Company Profile ...Dividend History.$0.65$0.49$5.27
389.Aerpio Pharmaceuticals (ARPO)$29.64 million-58.72%Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for ocular diseases. The company's lead product candidate is AKB-9778, a small molecule activator ...See Company Profile ...Dividend History.$0.7$0.61$4.25
390.Intec Pharma (NTEC)$29.41 million-88.03%Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery syst...See Company Profile ...Dividend History.$0.9$0.41$9.25
391.Midatech Pharma (MTP)$29.03 million780%Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates throug...See Company Profile ...Dividend History.$1.32$1.03$10.9
392.KemPharm (KMPH)$28.98 million-51.68%KemPharm, Inc., incorporated on May 28, 2014, is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated ...See Company Profile ...Dividend History.$0.86$0.71$5.47
393.Acer Therapeutics (ACER)$28.23 million-85.54%Acer Therapeutics Inc., a pharmaceutical company, develops therapies for the treatment of rare diseases with critical unmet medical needs. Its product candidates include Celiprolol for the treatment of vascular...See Company Profile ...Dividend History.$2.91$1.87$32.75
394.Entera Bio (ENTX)$28.02 million-17.38%Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product ...See Company Profile ...Dividend History.$2.52$1.35$6.4
395.Sophiris Bio (SPHS)$27.92 million-7.18%Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of products for the treatment of urological diseases. The company's primary product candidate is PRX302, which is in Ph...See Company Profile ...Dividend History.$0.77$0.71$3.05
396.AzurRx BioPharma (AZRX)$25.58 million-19.01%AzurRx BioPharma, Inc., incorporated on January 30, 2014, is a clinical development-stage biopharmaceutical company. The Company is engaged in the research and development of non-systemic biologics for the treatment of ...See Company Profile ...Dividend History.$0.98$0.86$3.75
397.ContraFect (CFRX)$25.48 million-78.43%ContraFect Corporation, incorporated on March 5, 2008, is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious ...See Company Profile ...Dividend History.$0.33$0.27$2.63
398.Zafgen (ZFGN)$24.55 million-86.73%Zafgen, Inc., incorporated on November 22, 2005, is a biopharmaceutical company. The Company is focused on improving the health and well-being of patients affected by obesity and complex metabolic disorders. ...See Company Profile ...Dividend History.$0.66$0.64$12.36
399.Aytu Bioscience (AYTU)$23.41 million68.35%Aytu BioScience, Inc., a specialty healthcare company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), insomnia, and male infertility in the U...See Company Profile ...Dividend History.$1.33$0.68$4.8
400.Histogenics (HSGX)$23.03 million203.11%Histogenics Corporation, incorporated on July 14, 2006, is a regenerative medicine company. The Company is focused on developing and commercializing products in the musculoskeletal segment of the marketplace. The Companys ...See Company Profile ...Dividend History.$0.27$0.08$1.43
401.Clearside Biomedical (CLSD)$23.02 million-36.92%Clearside Biomedical, Inc., incorporated on May 26, 2011, is a clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye. The Companys product candidates focus on ...See Company Profile ...Dividend History.$0.68$0.56$6.8
402.Sienna Biopharmaceuticals (SNNA)$22.85 million-58.68%Sienna Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of topical products in medical dermatology and aesthetics. The company's...See Company Profile ...Dividend History.$0.69$0.52$17.19
403.OncoSec Medical (ONCS)$22.09 million221.88%OncoSec Medical Incorporated, incorporated on February 8, 2008, is a biotechnology company. The Company is focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate an ...See Company Profile ...Dividend History.$2.06$1.8$19.6
404.Citius Pharmaceuticals (CTXR)$21.98 million22%Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. T...See Company Profile ...Dividend History.$1.22$0.86$2.52
405.Oragenics (OGEN)$21.92 million-41.76%Oragenics, Inc., incorporated on November 6, 1996, develops, markets and sells probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora. The ...See Company Profile ...Dividend History.$0.5$0$3.74
406.Rexahn Pharma (RNN)$21.06 million469.57%Rexahn Pharmaceuticals, Inc., incorporated on January 14, 2005, is a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of treatments for cancer. The Companys clinical-stage drug candidates in ...See Company Profile ...Dividend History.$5.24$4.71$23.28
407.Cellectar Biosciences (CLRB)$20.65 million46.45%Cellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., incorporated on June 24, 1996, is a clinical stage biopharmaceutical company. The Company is engaged in developing phospholipid ether-drug conjugates (PDCs) for the ...See Company Profile ...Dividend History.$2.27$1.22$4.28
408.Aileron Therapeutics (ALRN)$19.84 million-4.57%Aileron Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing a novel class of therapeutics in the United States. The company's lead product candidate is ALRN...See Company Profile ...Dividend History.$0.8$0.45$3.54
409.Biostage (BSTG)$19.14 million16.49%Biostage, Inc., formerly Harvard Apparatus Regenerative Technology, Inc., incorporated on May 3, 2012, is a biotechnology company. The Company is engaged in developing bioengineered organ implants based on its Cellframe ...See Company Profile ...Dividend History.$2.89$0.75$3.46
410.Soligenix (SNGX)$18.98 million8.72%Soligenix, Inc. (Soligenix), incorporated on January 16, 1987, is a late-stage biopharmaceutical company. The Company is focused on developing and commercializing products to treat rare diseases. The Company operates through ...See Company Profile ...Dividend History.$0.94$0.65$2.2
411.Heat Biologics (HTBX)$18.22 million-45.4%Heat Biologics, Inc., incorporated on June 10, 2008, is a development-stage company focused on developing allogeneic, off-the-shelf cellular therapeutic vaccines to combat a range of cancers. The Company is an ...See Company Profile ...Dividend History.$0.54$0.46$2.24
412.Pulmatrix (PULM)$17.14 million-68.14%Pulmatrix, Inc., incorporated on September 25, 2013, is a clinical stage biopharmaceutical company developing inhaled therapies to address serious pulmonary disease. The Company?ÇÖs product pipeline is focused on advancing treatments ...See Company Profile ...Dividend History.$0.86$0.72$4.6
413.Achieve Life Sciences (ACHV)$16.76 million97.52%Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers Cytisine, a plant-based alka...See Company Profile ...Dividend History.$2.39$1.04$5.25
414.Kitov Pharma (KTOV)$16.4 million29.92%Kitov Pharma Ltd, through its subsidiaries, operates as a development stage biopharmaceutical company in Israel. It develops combination drugs for the simultaneous treatment of pain caused by osteoarthritis and...See Company Profile ...Dividend History.$0.86$0.56$2.92
415.Adial Pharmaceuticals (ADIL)$16.06 million-68.97%Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders in the United States. Its lead product is AD0...See Company Profile ...Dividend History.$1.53$1.11$9.44
416.Kazia Therapeutics (KZIA)$15.75 million10.42%Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops therapies for a range of oncology indications. Its lead product is GDC-0084, a small molecule inhibitor of the PI3K AKT u0...See Company Profile ...Dividend History.$2.46$2.04$4.27
417.Neurotrope (NTRP)$15.72 million-71.99%Neurotrope, Inc., a biopharmaceutical company, focuses on the development of a product platform for the treatment of Alzheimer's disease (AD). Its lead product candidate is bryostatin, a natural product isolate...See Company Profile ...Dividend History.$1$0.81$9.38
418.Tetraphase Pharma (TTPH)$15.48 million-74.78%Tetraphase Pharmaceuticals, Inc. (Tetraphase), incorporated on July 7, 2006, is a clinical-stage biopharmaceutical company. The Company uses its chemistry technology to create antibiotics for multidrug-resistant infections. The Company is developing ...See Company Profile ...Dividend History.$0.29$0.23$3.31
419.Vical (VICL)$15.44 million-42.71%Vical Incorporated, incorporated on April 30, 1987, researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases. ...See Company Profile ...Dividend History.$0.68$0.6$10.29
420.CollPlant (CLGN)$15.44 million-6.9%CollPlant Holdings Ltd., a regenerative medicine company, focuses on developing and commercializing tissue repair products for three-dimensional (3D) bio-printing of tissues and organs, orthobiologics, and adva...See Company Profile ...Dividend History.$3.91$3.13$8.73
421.iBio (IBIO)$15.41 million-18.01%iBio, Inc., incorporated on April 17, 2008, is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to ...See Company Profile ...Dividend History.$0.62$0.5$1.4
422.TRACON Pharma (TCON)$15.27 million-19.05%TRACON Pharmaceuticals, Inc., incorporated on October 28, 2004, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for cancer, wet age-related macular degeneration ...See Company Profile ...Dividend History.$0.51$0.4$2.35
423.Ohr Pharma (OHRP)$15.25 million145%Ohr Pharmaceutical, Inc., incorporated on May 8, 2014, is a pharmaceutical company focused on the development of therapeutics and delivery technologies for the treatment of ocular disease. The Companys development ...See Company Profile ...Dividend History.$5.39$1.6$6.23
424.Cleveland BioLabs (CBLI)$15.24 million23.14%Cleveland BioLabs, Inc. (CBLI), incorporated on June 5, 2003, is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. ...See Company Profile ...Dividend History.$1.24$1$2.16
425.Oncolytics Biotech (ONCY)$15.24 million-61.2%Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing REOLYSIN, an im...See Company Profile ...Dividend History.$0.71$0.53$5.12
426.Onconova Therapeutics (ONTX)$13.85 million18.96%Onconova Therapeutics, Inc., incorporated on December 22, 1998, is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering ...See Company Profile ...Dividend History.$2.51$1.69$11.17
427.Genprex (GNPX)$13.75 million-20%Genprex, Inc., a clinical-stage gene therapy biotechnology company, develops immunogene therapy products for treating cancer. Its lead drug candidate is Oncoprex, which is in Phase II clinical trials for the tr...See Company Profile ...Dividend History.$0.88$0.64$2.56
428.Immuron (IMRN)$13.51 million-48.6%Immuron Limited, a biopharmaceutical company, focuses on the research and development of immunomodulatory polyclonal antibodies for the treatment and prevention of various diseases through its oral immunoglobul...See Company Profile ...Dividend History.$2.94$2.23$10.15
429.Regulus Therapeutics (RGLS)$13.24 million-23.66%Regulus Therapeutics Inc., incorporated on September 5, 2007, is a biopharmaceutical company focused on discovering and developing drugs that target microribonucleic acid (microRNAs) to treat a range of diseases. The ...See Company Profile ...Dividend History.$0.71$0.5$3.14
430.Dare Bioscience (DARE)$12.95 million9.87%Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's reproductive health products in the United States. The company intends to develop therapies in the...See Company Profile ...Dividend History.$0.78$0.6$3.25
431.Novelion Therapeutics (NVLN)$12.38 million-23.74%Novelion Therapeutics Inc, formerly QLT Inc., incorporated in 1981, is a biotechnology company. The Company is focused on the development and commercialization of ocular products that address the unmet medical ...See Company Profile ...Dividend History.$0.64$0.6$4.05
432.NovaBay Pharma (NBY)$12.33 million-37.97%NovaBay Pharmaceuticals, Inc., formerly NovaCal Pharmaceuticals, Inc., incorporated on April 19, 2010, is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription ...See Company Profile ...Dividend History.$0.48$0.23$4.04
433.Aevi Genomic Medicine (GNMX)$12 million-77.11%Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., incorporated on January 27, 2000, is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate ...See Company Profile ...Dividend History.$0.16$0.15$1.4
434.Realm Therapeutics (RLM)$11.89 million-86% ...See Company Profile ...Dividend History.$2.55$1.35$13
435.Vaxart (VXRT)$11.5 million-61.7%Vaxart, Inc., a clinical-stage company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus. It is also developing therapeutic immune-oncology vaccines ...See Company Profile ...Dividend History.$0.72$0.55$7.6
436.Conatus Pharma (CNAT)$11.42 million-80.54%Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines for the treatment of liver diseases in the United States. Its product candidates includ...See Company Profile ...Dividend History.$0.34$0.25$6.74
437.aTyr Pharma (LIFE)$11.4 million506%aTyr Pharma, Inc., incorporated on October 8, 2005, is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, ...See Company Profile ...Dividend History.$3.03$2.76$12.33
438.Trillium Therapeutics (TRIL)$10.94 million-79.53%Trillium Therapeutics Inc., a clinical-stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced hematologic malignancies, and solid ...See Company Profile ...Dividend History.$0.35$0.24$6.75
439.XTL BioPharma (XTLB)$10.87 million13.7%XTL Biopharmaceuticals Ltd., incorporated on March 9, 1993, is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its ...See Company Profile ...Dividend History.$1.97$1.43$3.85
440.Motif Bio (MTFB)$10.69 million-90.97%Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and l...See Company Profile ...Dividend History.$0.59$0.5$11.5
441.CytRx (CYTR)$10.5 million-30.67%CytRx Corporation, incorporated on February 28, 1985, is a biopharmaceutical research and development company specializing in oncology. The Company is focused on the clinical development of aldoxorubicin, its modified version ...See Company Profile ...Dividend History.$0.31$0.26$1.1
442.Navidea BioPharma (NAVB)$10.39 million508.8%Navidea Biopharmaceuticals, Inc. (Navidea), incorporated on April 28, 1988, is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The Company is developing multiple ...See Company Profile ...Dividend History.$0.61$0.49$7.4
443.Ritter Pharma (RTTR)$10.05 million100%Ritter Pharmaceuticals, Inc., incorporated on October 16, 2008, develops therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. The Companys segment is focusing on the development and ...See Company Profile ...Dividend History.$1.2$0.47$2.56
444.Novus Therapeutics (NVUS)$10.01 million-53.79%Novus Therapeutics, Inc., a pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. Its lead product is (OP-02), a surfactant-based combination drug product ...See Company Profile ...Dividend History.$0.74$0.57$5.41
445.Therapix Biosciences (TRPX)$9.45 million-14.15%Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include THX-110 for the treatment of Tourette syndrome, Obstructive Sleep Apnea, and pain; THX-130 for the treatment of Mild Cognitive Impairment and Traumatic Brain Injury; THX-150 for the treatment of infectious diseases; ...See Company Profile ...Dividend History.$2.79$2.04$9.3
446.Capricor Therapeutics (CAPR)$9.32 million556.1%Capricor Therapeutics, Inc., incorporated on January 26, 2007, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapeutics. The Company focuses on discovering, developing and commercializing ...See Company Profile ...Dividend History.$2.69$2.3$12
447.Cyclacel Pharma (CYCCP)$9.22 million-22.4%Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include sapaci...See Company Profile ...Dividend History.$4.85$4.46$7
448.Auris Medical Holding AG (EARS)$9.17 million542.22%Auris Medical Holding AG, incorporated on April 15, 1998, is a holding and clinical-stage biopharmaceutical company focused on the development of products for the treatment of inner ear disorders. The ...See Company Profile ...Dividend History.$2.89$2.41$39.4
449.Tenax Therapeutics (TENX)$8.9 million9.09%Tenax Therapeutics, Inc., incorporated on April 17, 2008, is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Companys ...See Company Profile ...Dividend History.$1.32$1.03$6.39
450.Diffusion Pharma (DFFN)$8.77 million-7.04%Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, incorporated on June 17, 2015, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The ...See Company Profile ...Dividend History.$1.85$1.83$11
451.ARCA biopharma (ABIO)$8.5 million1538.24%ARCA biopharma, Inc. (ARCA), incorporated on March 16, 2004, is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Companys lead product candidate ...See Company Profile ...Dividend History.$5.57$4.68$20.45
452.Synthetic Biologics (SYN)$8.27 million-12.11%Synthetic Biologics, Inc., incorporated on December 23, 2008, is a clinical-stage company. The Company is engaged in developing therapeutics to protect the gut microbiome while targeting pathogen-specific diseases. The Companys ...See Company Profile ...Dividend History.$0.49$0.37$8
453.Eyegate Pharma (EYEG)$8.14 million548.94%Eyegate Pharmaceuticals, Inc., incorporated on December 28, 2004, is a clinical-stage specialty pharmaceutical company. The Company is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases ...See Company Profile ...Dividend History.$3.05$2.25$9.6
454.Tonix Pharma Holding (TNXP)$7.99 million-76.36%Tonix Pharmaceuticals Holding Corp. (Tonix), incorporated on November 16, 2007, is a clinical-stage pharmaceutical company. The Companys drug development programs are directed toward disorders affecting the central nervous system (CNS), ...See Company Profile ...Dividend History.$0.52$0.37$9.9
455.Can-Fite Biopharma (CANF)$7.98 million89.68%Can Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer. The Company?ÇÖs drugs are CF101 for Psoriasis treatment, RA treatment, for ...See Company Profile ...Dividend History.$2.39$2.14$25.95
456.Gemphire Therapeutics (GEMP)$7.97 million-39.8%Gemphire Therapeutics Inc., incorporated on October 30, 2014, is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutics to treat cardiovascular and metabolic diseases. ...See Company Profile ...Dividend History.$0.49$0.42$2.52
457.Phio Pharmaceuticals (PHIO)$7.66 million-8.33%Phio Pharmaceuticals Corp., a biotechnology company, focuses on discovering and developing immuno-oncology therapeutics to treat cancer. The company's lead product candidate is RXI-109, an sd-rxRNA that reduces...See Company Profile ...Dividend History.$0.3$0.27$2.19
458.Jaguar Animal Health (JAGX)$7.08 million413.64%Jaguar Animal Health, Inc., incorporated on June 6, 2013, is an animal health company. The Company is focused on developing and commercializing gastrointestinal products for companion and production animals, foals, ...See Company Profile ...Dividend History.$1.13$1$175
459.Titan Pharma (TTNP)$6.75 million-68.02%Titan Pharmaceuticals, Inc. (Titan), incorporated on February 7, 1992, is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Companys segment ...See Company Profile ...Dividend History.$0.43$0.4$5.04
460.Proteon Therapeutics (PRTO)$6.72 million-83.7%Proteon Therapeutics, Inc., incorporated on March 24, 2006, is a late-stage biopharmaceutical company, which focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular ...See Company Profile ...Dividend History.$0.37$0.27$3.94
461.Cyclacel Pharma (CYCC)$6.54 million-28.85%Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include sapaci...See Company Profile ...Dividend History.$0.43$0.28$1.73
462.ContraVir Pharma (CTRV)$5.88 million1178.57%ContraVir Pharmaceuticals, Inc., incorporated on May 15, 2013, is a biopharmaceutical company. The Company focuses on the development of antiviral drugs for the treatment of Hepatitis B virus (HBV) infections. ...See Company Profile ...Dividend History.$3.58$2.69$56.7
463.Advaxis (ADXS)$5.69 million57.89%Advaxis, Inc., incorporated on February 28, 2002, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are ...See Company Profile ...Dividend History.$0.3$0.26$15
464.DelMar Pharma (DMPI)$5.57 million87.5%DelMar Pharmaceuticals, Inc., incorporated on June 24, 2009, is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials ...See Company Profile ...Dividend History.$0.64$0.55$8.5
465.Xenetic Biosciences (XBIO)$5.54 million-9.76%Xenetic Biosciences, Inc., incorporated on August 9, 2011, is a clinical-stage biopharmaceutical company. The Company is focused on the research and development of certain pharmaceutical products for use in humans ...See Company Profile ...Dividend History.$1.48$1.35$54.6
466.InVivo Therapeutics (NVIV)$5.47 million-55.96%InVivo Therapeutics Holdings Corp., formerly Design Source, Inc., incorporated on April 2, 2003, is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing ...See Company Profile ...Dividend History.$0.67$0.52$2.75
467.Cytori Therapeutics (CYTX)$4.6 million-28.38%Cytori Therapeutics, Inc., a therapeutics company, together with its subsidiaries, develops regenerative and oncologic therapies from its proprietary cell therapy and nanoparticle platforms for variou...See Company Profile ...Dividend History.$0.21$0.13$0.67
468.Hemispherx BioPharma (HEB)$4.54 million900%Hemispherx Biopharma, Inc. (Hemispherx), incorporated on December 17, 1990, is a specialty pharmaceutical company. The Company is engaged in the clinical development of drug therapies based on natural immune system ...See Company Profile ...Dividend History.$1.8$1.51$14.96
469.GTx (GTXI)$4.12 million53.85%GTx, Inc., incorporated on October 4, 2003, is a biopharmaceutical company focused on the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast ...See Company Profile ...Dividend History.$1.2$0.74$25.6
470.BioPharmX (BPMX)$4.11 million256.55%BioPharmX Corporation, incorporated on April 24, 2014, is a specialty pharmaceutical company. The Company is focused on utilizing its drug delivery technologies to develop and commercialize prescription and over-the-counter (OTC) ...See Company Profile ...Dividend History.$0.39$0$6.75
471.Neuralstem (CUR)$3.7 million474.19%Neuralstem, Inc. (Neuralstem), incorporated on February 28, 2001, is a clinical-stage biopharmaceutical company. The Company is engaged in research, development and commercialization of central nervous system therapies based on its ...See Company Profile ...Dividend History.$1.78$1.5$24.4
472.Cellect Biotechnology (APOP)$1.54 million-75.24%Cellect Biotechnology Ltd., a biotechnology company, focuses on developing technologies for the functional selection of stem cells in the field of regenerative medicine and stem cell therapies in Israel. It is ...See Company Profile ...Dividend History.$0.52$0.4$6.01
473.ImmunoCellular Therapeutics (IMUC)$1.43 million70.5%ImmunoCellular Therapeutics, Ltd., incorporated on March 20, 1987, is a clinical-stage biotechnology company. The Company is developing immune-based therapies for the treatment of cancers. The Companys cancer immunotherapies target cancer ...See Company Profile ...Dividend History.$0.03$0.01$0.25
474.Anthera Pharma (ANTH)$1.25 million-17%Anthera Pharmaceuticals, Inc. (Anthera), incorporated on October 9, 2004, is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies ...See Company Profile ...Dividend History.$0.06$0.01$0.1
Top 10 Biotech Stocks All Biotech Stocks All Biotech ETFs Top Dividend-paying Biotech Stocks
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.

Other Popular Stocks Lists:

 ◐ List of Accident Health Insurance Stocks

 ◐ List of Finance Companies Stocks

 ◐ List of Property Casualty Insurance Nec Stocks

 ◐ List of Wholesale Distributors Stocks

 ◐ List of Trucking Freight Courier Services Stocks

 ◐ List of Water Waste Treatment Systems Stocks

 ◐ List of Trading Mining Stocks

 ◐ List of Tools Hardware Stocks

 ◐ List of Tobacco Stocks

 ◐ List of Television Services Stocks

 ◐ List of Technology Stocks

 ◐ List of Spirit Wine Stocks

 ◐ List of Technology Services Stocks

 ◐ List of Specialty Foods Stocks

 ◐ List of Specialty Insurers Stocks

 ◐ List of Software Stocks

 ◐ List of Specialized Reits Nec Stocks

 ◐ List of Semiconductors Stocks

 ◐ List of Shoe Manufacturing Stocks

 ◐ List of Retail Computer Software Equipment Stocks

 ◐ List of Savings Institutions Stocks

 ◐ List of Retail Building Materials Stocks

 ◐ List of Restaurants Stocks

 ◐ List of Recreational Products Stocks

 ◐ List of Rental Leasing Companies Stocks

 ◐ List of Radio Tv Broadcasting Stocks

 ◐ List of Property Insurance Stocks

 ◐ List of Property Casualty Insurers Stocks

 ◐ List of Private Equity Stocks

 ◐ List of Precision Instruments Stocks

 ◐ List of Precious Metals Stocks

 ◐ List of Power Generation Stocks

 ◐ List of Pollution Control Equipment Stocks

 ◐ List of Plastic Products Stocks

 ◐ List of Paints Coatings Stocks

 ◐ List of Packaged Foods Stocks

 ◐ List of Others Miscellaneous Stocks

 ◐ List of Other Transportation Stocks

 ◐ List of Other Pharmaceuticals Stocks

 ◐ List of Ordnance Accessories Stocks

 ◐ List of Ophthalmic Goods Stocks

 ◐ List of Oilfield Services Equipment Stocks

 ◐ List of Oil Gas Stocks

 ◐ List of Oil Gas Transmission Stocks

 ◐ List of Oil Gas Exploration Stocks

 ◐ List of Office Reits Stocks

 ◐ List of Newspapers Magazines Stocks

 ◐ List of Multiline Insurance Brokers Nec Stocks

 ◐ List of Multi Sector Companies Stocks

 ◐ List of Movies Entertainment Stocks

 ◐ List of Mortgage Reits Stocks

 ◐ List of Mining Quarrying Minerals Stocks

 ◐ List of Manufacturing Industries Stocks

 ◐ List of Medical Products Stocks

 ◐ List of Medical Nursing Services Stocks

 ◐ List of Medical Electronics Stocks

 ◐ List of Medical Dental Instruments Stocks

 ◐ List of Meat Poultry Fish Stocks

 ◐ List of Major Pharmaceuticals Stocks

 ◐ List of Major Chemicals Stocks

 ◐ List of Major Banks Stocks

 ◐ List of Life Insurance Stocks

 ◐ List of Investors Services Stocks

 ◐ List of Investment Managers Stocks

 ◐ List of Investment Funds Stocks

 ◐ List of Investment Bankers Brokers Stocks

 ◐ List of Integrated Oil Companies Stocks

 ◐ List of Insurance Stocks

 ◐ List of Hotels Resorts Stocks

 ◐ List of Hospital Nursing Management Stocks

 ◐ List of Health Care Stocks

 ◐ List of Health Care Equipment Services Stocks

 ◐ List of Greeting Cards Stocks

 ◐ List of Forest Products Stocks

 ◐ List of Food Distributors Stocks

 ◐ List of Fluid Controls Stocks

 ◐ List of Exhibition Conference Services Stocks

 ◐ List of Electronics Distribution Stocks

 ◐ List of Educational Services Stocks

 ◐ List of Edp Services Stocks

 ◐ List of Drug Manufacturer Stocks

 ◐ List of Retail Stores Stocks

 ◐ List of Drug Development Stocks

 ◐ List of Drug Delivery Stocks

 ◐ List of Drilling Stocks

 ◐ List of Diversified Financial Services Stocks

 ◐ List of Diversified Electronic Products Stocks

 ◐ List of Consumer Lending Nec Stocks

 ◐ List of Consumer Finance Services Stocks

 ◐ List of Consumer Electronics Video Stocks

 ◐ List of Construction Agri Equipment Trucks Stocks

 ◐ List of Conglomerate Stocks

 ◐ List of Computer Software Programming Data Processing Stocks

 ◐ List of Computer Software Prepackaged Software Stocks

 ◐ List of Computer Peripheral Equipment Stocks

 ◐ List of Computer Manufacturing Stocks

 ◐ List of Computer Communications Equipment Stocks

 ◐ List of Commercial Reits Nec Stocks

 ◐ List of Commercial Leasing Stocks

 ◐ List of Commercial Banks Stocks

 ◐ List of Coal Mining Stocks

 ◐ List of Clothing Shoes Accessory Stocks

 ◐ List of Catalog Specialty Distribution Stocks

 ◐ List of Building Operators Stocks

 ◐ List of Building Contractors Nonresidential Stocks

 ◐ List of Broadcasting Stocks

 ◐ List of Books Stocks

 ◐ List of Biotech Research Stocks

 ◐ List of Biotech Instruments Stocks

 ◐ List of Biotech Diagnostics Stocks

 ◐ List of Biotech Apparatus Stocks

 ◐ List of Biotech Stocks

 ◐ List of Biotech Products Stocks

 ◐ List of Beverages Stocks

 ◐ List of Banks Stocks

 ◐ List of Auto Parts Oem Stocks

 ◐ List of Auto Manufacturing Stocks

 ◐ List of Auto Accessories Stocks

 ◐ List of Apparel Stocks

 ◐ List of Amusement Recreation Stocks

 ◐ List of Aluminum Stocks

 ◐ List of Air Freight Stocks

 ◐ List of Agricultural Chemicals Stocks

 ◐ List of Aerospace Defense Stocks

 ◐ List of Paper Basic Industries Stocks

 ◐ List of Reits Finance Stocks

 ◐ List of Water Supply Public Utilities Stocks

 ◐ List of Water Supply Basic Industries Stocks

 ◐ List of Transportation Services Transportation Stocks

 ◐ List of Transportation Services Consumer Services Stocks

 ◐ List of Textiles Consumer Non Durables Stocks

 ◐ List of Textiles Basic Industries Stocks

 ◐ List of Telecommunications Equipment Technology Stocks

 ◐ List of Telecommunications Equipment Public Utilities Stocks

 ◐ List of Telecommunications Equipment Consumer Services Stocks

 ◐ List of Telecommunications Equipment Consumer Non Durables Stocks

 ◐ List of Telecommunications Equipment Consumer Durables Stocks

 ◐ List of Telecommunications Equipment Basic Industries Stocks

 ◐ List of Steel Iron Capital Goods Stocks

 ◐ List of Steel Iron Basic Industries Stocks

 ◐ List of Specialty Chemicals Consumer Durables Stocks

 ◐ List of Specialty Chemicals Capital Goods Stocks

 ◐ List of Specialty Chemicals Basic Industries Stocks

 ◐ List of Reits Consumer Services Stocks

 ◐ List of Recreational Products Toys Consumer Services Stocks

 ◐ List of Recreational Products Toys Consumer Non Durables Stocks

 ◐ List of Real Estate Finance Stocks

 ◐ List of Real Estate Consumer Services Stocks

 ◐ List of Railroads Transportation Stocks

 ◐ List of Railroads Capital Goods Stocks

 ◐ List of Publishing Miscellaneous Stocks

 ◐ List of Publishing Consumer Services Stocks

 ◐ List of Publishing Consumer Durables Stocks

 ◐ List of Professional Services Technology Stocks

 ◐ List of Professional Services Consumer Services Stocks

 ◐ List of Paper Consumer Services Stocks

 ◐ List of Package Goods Cosmetics Consumer Non Durables Stocks

 ◐ List of Package Goods Cosmetics Basic Industries Stocks

 ◐ List of Other Specialty Stores Consumer Services Stocks

 ◐ List of Other Specialty Stores Basic Industries Stocks

 ◐ List of Other Consumer Services Consumer Services Stocks

 ◐ List of Other Consumer Services Miscellaneous Stocks

 ◐ List of Oil Refining Marketing Transportation Stocks

 ◐ List of Oil Refining Marketing Energy Stocks

 ◐ List of Oil Gas Production Energy Stocks

 ◐ List of Oil Gas Production Public Utilities Stocks

 ◐ List of Office Equipment Supplies Services Miscellaneous Stocks

 ◐ List of Office Equipment Supplies Services Consumer Services Stocks

 ◐ List of Natural Gas Distribution Public Utilities Stocks

 ◐ List of Office Equipment Supplies Services Consumer Durables Stocks

 ◐ List of Motor Vehicles Consumer Services Stocks

 ◐ List of Natural Gas Distribution Energy Stocks

 ◐ List of Motor Vehicles Consumer Non Durables Stocks

 ◐ List of Miscellaneous Consumer Services Stocks

 ◐ List of Miscellaneous Basic Industries Stocks

 ◐ List of Military Government Technical Consumer Services Stocks

 ◐ List of Military Government Technical Capital Goods Stocks

 ◐ List of Military Government Technical Basic Industries Stocks

 ◐ List of Metal Fabrications Energy Stocks

 ◐ List of Metal Fabrications Consumer Durables Stocks

 ◐ List of Metal Fabrications Capital Goods Stocks

 ◐ List of Metal Fabrications Basic Industries Stocks

 ◐ List of Medical Specialities Health Care Stocks

 ◐ List of Medical Specialities Capital Goods Stocks

 ◐ List of Marine Transportation Transportation Stocks

 ◐ List of Marine Transportation Consumer Services Stocks

 ◐ List of Marine Transportation Capital Goods Stocks

 ◐ List of Industrial Specialties Health Care Stocks

 ◐ List of Industrial Specialties Consumer Durables Stocks

 ◐ List of Industrial Specialties Capital Goods Stocks

 ◐ List of Industrial Machinery Components Miscellaneous Stocks

 ◐ List of Industrial Machinery Components Technology Stocks

 ◐ List of Industrial Machinery Components Energy Stocks

 ◐ List of Industrial Machinery Components Consumer Durables Stocks

 ◐ List of Industrial Machinery Components Capital Goods Stocks

 ◐ List of Homebuilding Consumer Services Stocks

 ◐ List of Homebuilding Consumer Non Durables Stocks

 ◐ List of Homebuilding Capital Goods Stocks

 ◐ List of Home Furnishings Consumer Services Stocks

 ◐ List of Homebuilding Basic Industries Stocks

 ◐ List of Home Furnishings Consumer Durables Stocks

 ◐ List of Home Furnishings Basic Industries Stocks

 ◐ List of Food Chains Consumer Services Stocks

 ◐ List of Food Chains Consumer Non Durables Stocks

 ◐ List of Farming Seeds Milling Consumer Non Durables Stocks

 ◐ List of Farming Seeds Milling Consumer Services Stocks

 ◐ List of Environmental Services Public Utilities Stocks

 ◐ List of Environmental Services Consumer Non Durables Stocks

 ◐ List of Environmental Services Basic Industries Stocks

 ◐ List of Engineering Construction Capital Goods Stocks

 ◐ List of Electronic Components Technology Stocks

 ◐ List of Engineering Construction Basic Industries Stocks

 ◐ List of Electronic Components Consumer Non Durables Stocks

 ◐ List of Electronic Components Consumer Durables Stocks

 ◐ List of Electrical Products Technology Stocks

 ◐ List of Electronic Components Capital Goods Stocks

 ◐ List of Electrical Products Capital Goods Stocks

 ◐ List of Electrical Products Consumer Durables Stocks

 ◐ List of Electric Utilities Public Utilities Stocks

 ◐ List of Electric Utilities Energy Stocks

 ◐ List of Electric Utilities Basic Industries Stocks

 ◐ List of Diversified Commercial Services Technology Stocks

 ◐ List of Diversified Commercial Services Finance Stocks

 ◐ List of Diversified Commercial Services Consumer Services Stocks

 ◐ List of Containers Packaging Capital Goods Stocks

 ◐ List of Containers Packaging Consumer Durables Stocks

 ◐ List of Containers Packaging Basic Industries Stocks

 ◐ List of Consumer Specialties Consumer Services Stocks

 ◐ List of Consumer Specialties Consumer Non Durables Stocks

 ◐ List of Consumer Specialties Consumer Durables Stocks

 ◐ List of Consumer Electronics Appliances Energy Stocks

 ◐ List of Consumer Electronics Appliances Consumer Non Durables Stocks

 ◐ List of Consumer Electronics Appliances Consumer Durables Stocks

 ◐ List of Business Services Technology Stocks

 ◐ List of Business Services Finance Stocks

 ◐ List of Business Services Miscellaneous Stocks

 ◐ List of Building Products Consumer Durables Stocks

 ◐ List of Business Services Consumer Services Stocks

 ◐ List of Building Products Capital Goods Stocks

 ◐ List of Building Materials Consumer Services Stocks

 ◐ List of Building Materials Capital Goods Stocks

 ◐ List of Automotive Aftermarket Consumer Services Stocks

 ◐ List of Automotive Aftermarket Consumer Durables Stocks

 ◐ List of Automotive Aftermarket Capital Goods Stocks

 ◐ List of Aerospace Transportation Stocks

 ◐ List of Aerospace Capital Goods Stocks

 ◐ List of Advertising Technology Stocks

 ◐ List of Advertising Consumer Services Stocks

 ◐ List of Advertising Stocks

 ◐ List of Telecommunications Equipment Stocks

 ◐ List of Water Supply Stocks

 ◐ List of Transportation Services Stocks

 ◐ List of Textiles Stocks

 ◐ List of Steel Iron Stocks

 ◐ List of Specialty Chemicals Stocks

 ◐ List of Recreational Products Toys Stocks

 ◐ List of Real Estate Investment Trusts Stocks

 ◐ List of Paper Stocks

 ◐ List of Real Estate Stocks

 ◐ List of Railroads Stocks

 ◐ List of Publishing Stocks

 ◐ List of Professional Services Stocks

 ◐ List of Package Goods Cosmetics Stocks

 ◐ List of Other Specialty Stores Stocks

 ◐ List of Other Consumer Services Stocks

 ◐ List of Oil Refining Marketing Stocks

 ◐ List of Oil Gas Production Stocks

 ◐ List of Office Equipment Supplies Services Stocks

 ◐ List of Natural Gas Distribution Stocks

 ◐ List of Motor Vehicles Stocks

 ◐ List of Miscellaneous Stocks

 ◐ List of Military Government Technical Stocks

 ◐ List of Metal Fabrications Stocks

 ◐ List of Medical Specialities Stocks

 ◐ List of Marine Transportation Stocks

 ◐ List of Industrial Specialties Stocks

 ◐ List of Homebuilding Stocks

 ◐ List of Industrial Machinery Components Stocks

 ◐ List of Home Furnishings Stocks

 ◐ List of Food Chains Stocks

 ◐ List of Farming Seeds Milling Stocks

 ◐ List of Environmental Services Stocks

 ◐ List of Engineering Construction Stocks

 ◐ List of Electronic Components Stocks

 ◐ List of Electrical Products Stocks

 ◐ List of Electric Utilities Stocks

 ◐ List of Diversified Commercial Services Stocks

 ◐ List of Containers Packaging Stocks

 ◐ List of Consumer Specialties Stocks

 ◐ List of Consumer Electronics Appliances Stocks

 ◐ List of Business Services Stocks

 ◐ List of Building Products Stocks

 ◐ List of Building Materials Stocks

 ◐ List of Automotive Aftermarket Stocks

 ◐ List of Aerospace Stocks

 ◐ List of Consumer Services Stocks

 ◐ List of Transportation Stocks

 ◐ List of Public Utilities Stocks

 ◐ List of Energy Stocks

 ◐ List of Finance Stocks

 ◐ List of Consumer Non Durables Stocks

 ◐ List of Capital Goods Stocks

 ◐ List of Basic Industries Stocks

 ◐ List of Consumer Durables Stocks

 ◐ List of Gold Stocks

 ◐ List of Silver Stocks

 ◐ List of Iron Stocks

 ◐ List of Steel Stocks

 ◐ List of Platinum Stocks

 ◐ List of Palladium Stocks

 ◐ List of Dogs Of The Dow Stocks

 ◐ List of 5g Stocks

 ◐ List of Residential Reit Stocks

 ◐ List of Office Reit Stocks

 ◐ List of Retail Reit Stocks

 ◐ List of Hotel Reit Stocks

 ◐ List of Industrial Reit Stocks

 ◐ List of Healthcare Reit Stocks

 ◐ List of Diversified Reit Stocks

 ◐ List of Reit Stocks

 ◐ List of Low Volatility Stocks

 ◐ List of Telecom Stocks

 ◐ List of China Stocks

 ◐ List of Nasdaq Stocks

 ◐ List of Biofuels Stocks

 ◐ List of Gaming Stocks

 ◐ List of Meat Stocks

 ◐ List of Bank Stocks

 ◐ List of Internet Stocks

 ◐ List of Natural Resources Stocks

 ◐ List of Blockchain Stocks

 ◐ List of Airlines Stocks

 ◐ List of Agriculture Stocks

 ◐ List of Water Stocks

 ◐ List of Russia Stocks

 ◐ List of Renewable Energy Stocks

 ◐ List of India Stocks

 ◐ List of Mexico Stocks

 ◐ List of Newspaper Stocks

 ◐ List of Coffee Stocks

 ◐ List of Fast Food Stocks

 ◐ List of Sidebardetailssector B4amp Stocks

 ◐ List of Sectordivlist B4amp Stocks

 ◐ List of Subsectorstklist B4amp Stocks

 ◐ List of Subsectorstklistdbl B4amp Stocks

 ◐ List of Subsectorstklisttop B4amp Stocks

 ◐ List of Busnlist B4amp Stocks

Stocks of Other Sectors

▶ Stock List of Sector

▶ Stock List of Basic Industries Sector

▶ Stock List of Basic Materials Sector

▶ Stock List of Capital Goods Sector

▶ Stock List of Communication Services Sector

▶ Stock List of Consumer Cyclical Sector

▶ Stock List of Consumer Defensive Sector

▶ Stock List of Consumer Durables Sector

▶ Stock List of Consumer Non-Durables Sector

▶ Stock List of Consumer Services Sector

▶ Stock List of Energy Sector

▶ Stock List of Finance Sector

▶ Stock List of Financial Services Sector

▶ Stock List of Health Care Sector

▶ Stock List of Industrials Sector

▶ Stock List of Miscellaneous Sector

▶ Stock List of Public Utilities Sector

▶ Stock List of Real Estate Sector

▶ Stock List of Services Sector

▶ Stock List of Technology Sector

▶ Stock List of Transportation Sector

▶ Stock List of Utilities Sector


Search This Site